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The application of computer modelling and parameter 
identification techniques are addressed with specific 
reference to the adult respiratory distress syndrome 
and the associated mismatch in the ventilation/ 
perfusion distribution. A literature survey and a 
discussion of related physiology serve as an intro-
duction to the identification of the problem and the 
philosophy of its solution. 
A computer model of the respiratory system is dis-
cussed followed by simulation results, including a 
parameter sensitivity exercise. The application of 
the model in the clinical environment is demonstrated 
and the thesis is concluded with the definition of a 
ventilation/perfusion index that may serve as a use-
ful clinical indicator for both the early identifi-
cation and management of patients susceptible to the 
adult respiratory distress syndrome (ARDS). 
i. 
The author wishes to express his gratitude towards 
the South African Medical Service for the support 
provided in the course of the research work under-
taken, as well as Dr. D.A. Boonzaier from the Univer-
sity of Cape Town for his guidance and assistance 
over an extended period. 
ii. 
TABLE OF <DffFffl.'S 
CHAPl'ER 1 
Introduction 































Estimation and Evaluation of Ventilation-
Perfusion Ratios 
Experimental Investigations 
Gas Exchange in the Lungs 
2.6.1 Intrcxiuction 
2.6.2 Gas Transfer in ARDS 
Lung Mechanics 
2.7.1 Surfactant and Compliance 
2.7.2 Pulmonary ~dema 
Prognosis and Prediction in Patient Management 
2.8.1 General 
2.8.2 ARDS Patients 
Modelling and Computer Programs 
2.9.1 Models 










































Elastic Properties of the Lung 
Transport of Respiratory Gases 
Acid-Base Status 








Respiration Haneostasis . 









Criteria for Diagnosis 
Clinical States Associated with ARDS 
Pathophysiology 
4.3.1 Pulmonary Oedema 
4.3.2 Surfactant Abnormalities 
4.3.3 Haemodynamic Disorders 
Ventilation/Perfusion Relationships and Gas Exchange 
in Lungs 
























Perfusion Ratio (VA/Q) 58 
4.4.2 Gas Transfer in ARDS patients 60 











Mathematical Model of the Gas Exchange Process in 
the Lungs 
5.2.1 Model F.quations 










5.2.3 Physiological Shunt and Dead Space 
5.2.4 Computer Simulation Program 











Parameter Sensitivity Analysis 








Interrelatedness of Parameters and the Clinical 
Relevance of this relationship. 
VA/Q Distribution 
The Physiological Shunt as a Diagnostic Indicator 
Parameter Identification Techniques 





Definition of the VA/Q Index .. 
Clinical Significance of the VA/Q I~de~ 
Sensitivity and Specificity of the VA/Q 
Index 
Method of Physiological Measurements 





APPENDIX A - MODEL PARAMETERS AND VARIABLES 
APPENDIX B - NEWTON RAPHSON ALGORITHM 
APPENDIX C - MODEL SENSITIVITY ANALYSIS 































LIST OF FIGUBES 










Diagrammatic representation of the anatomy of the 
respiratory system and circulation. 
Lung volumes with typical values for a heal thy young 
adult male ( 70 kg) . 
Representative static volume-pressure relationship of 
lung for a cycle from O to 30 cm H20 - from D.R. 
Glaister et al. (1973). Bulk elastic properties of 
exised lungs and the effect of a transpulmonary 
pressure gradient. Resp. Physiol., 17; 347-364. 
Comparison of pressures (mmHg) in the pulmonary and 
systemic circulations - from J.B. West (1979). 
Respiratory Physiology. Williams and Wilkins Company; 
33. 
Shift of the o2 dissociation curve by pH, PCD2 and Temp 
- from J.B. West (1979). Respiratory Physiology. 
Williams and Wilkins Company; 73. 
co2 dissociation curves for blood of different o2 
saturations. Note that oxygenated blood carries less 
CO2 for the same PC02. The "physiological" curve 
between arterial and mixed venous blood is also shown -
from J.B. West (1979). Respiratory Physiology. 
Williams and Wilkins Company; 77 
Davenport diagram showing the relationships between 
HC0 3, pH and PC02• A shows the buffer line BAC. B 
shows the changes occurring in respiratory and 
metabolic acidosis and alkalosis - from J.B. West 
(1979). Respiratory Physiology. Williams and Wilkins 
Company; 81. 
Diagrammatic representation of the respiratory gas 
transport system - from F.S. Grodins and S.M. Yamashiro 
(1978 ). Respiratory function of the lung and its 
control • Macmillan Publishing Co. ; 5. 




Diagrammatic representation of the homeostatic sub-
systems. 
































Block diagram of the modified respiratory chemostat 
(i.e. the metabolic servomechanism) including a dual 
role of VCD2 (information flow to controller, material 
flow to gas exchanger) - from F.S. Grodins and S.M. 
Yamashiro (1978). Respiratory function of the lung and 
its control. Macmillan Publishing Co.; 118. 
• Pathophysiology of ARDS - data from T.L. Petty (1982). 
Another look at ARDS. Chest, 82; 99. 
Examples of ventilation-perfusion distributions in 
normal subjects. The left panel shows the result in a 
young subject and the right panel the results in an 
older man - from J.B. West (editor) (1977). Bio-
engineering aspects of the lung. Marcel Dekker, Inc.; 
405. 
Ventilation/Perfusion distribution in a patient with 
the adult respiratory distress syndrome - from R.D. 
Dantzker (1979). Arn. Rev. Resp. Dis., 120; 1039. 
Intermittent mandatory ventilation with PEEP. 
Schema tic representation of the therapeutic goals in 
ARDS patients. 
Diagram ma tic representation of the modelling and · 
simulation process for biological systems. 
.. 
Block diagram of a gas exchange model for a uniform 
compartment in the lung. 
Block diagram of a N-compartmental pulmonary gas 
exchange model. 
Block diagram of the systems equations. 
Illustration of a ventilation-perfusion mismatch. 
Simplified flow chart for the simulation program. 
Flow chart for master simulation program. 
Respiratory Input/Output system. 
Flow chart of a parameter identification technique. 
VA/Q - Index compensating factor. 






















LIST OF TART8, 
Title 
Numerical values of Respiratory Zone (Model for average 
adult) - from E.R. Weibel (1963). Morphometry of the 
Human Lung. Academic Press Inc. 
Algorithm for the simulation program. 
























LIST OF GRAim 
Title 
Log-normal Ventilation/Perfusion distribution. 
Bimodal Log-Normal Ventilation/Perfusion distribution 
(low VA/Q = 0,003). 
Bimodal Log-Normal Ventilation/Perfusion distribution 
(low VA/Q = 0,003). 
Bimodal Log-Normal Ventilation/Perfusion distribution 
(low VA/Q = 0,124). 
Bimodal Log-Normal Ventilation/Perfusion distribution 
(low VA/Q = 0,124). 
Relative blood redistribution: bimodal ventilation/ 
perfusion distribution (low VA/Q = 0,124). 
Relative blood redistribution: bimodal ventilation/ 
perfusion distribution (low VA/Q = 0,003). 
Relative blood redistribution: bimodal ventilation/ 
perfusion distribution : arterial Pa)2• 
Relative blood redistribution: bimodal ventilation/ 
perfusion distributions : alveolar dead space. 
Model sensitivity analysis : oxygen consumption (low 
V A/Q = 0, 124). 
Model sensitivity analysis : oxygen consumption (low 
VA/Q = 0,003). 
Model sensitivity analysis carbon dioxide output (low 
VA/Q = 0,124). 
Model sensitivity analysis carbon dioxide output (low 
VA/Q = 0,003). 
Model sensitivity analysis : total inspired alveolar 
ventilation (low VA/Q = 0,124). 
Model sensitivity analysis : total inspired ventilation 
(low VA/Q = 0,003). 
Model sensitivity analysis: total pulmonary capillary 
perfusion (low VA/Q = 0,124). 
Model sensitivity analysis: total pulmonary capillary 




































Model sensitivity analysis effective inspired gas 
pressure (low VA/Q = 0,124). 
Model sensitiyi~y analysis effective inspired gas 
pressure (low VA/Q = 0,003). 
Model.se?sitivity analysis haemoglobin concentration 
(low VA/Q = 0,124). 
Model.se~sitivity analysis haemoglobin concentration 
(low VA/Q = 0,003). 
¥od~l sensitivity analysis : blood temperature (low 
VA/Q = 0,124). 
Model sensi ti vi ty analysis : . . blood temperature (low 
VA/Q = 0,003). 
Model sensitivity analysis 
0,124). 
haema tocri t ( low V A/Q = 
Model sensitivity analysis haematocri t (low V A/Q = 
0,003). 
Relative blood redistribution: bimodal ventilation/ 
perfusion distribution. 
Bimodal ventilation/perfusion distribution: changes in 
the low VA/Q region (L/blood = 55%). 
Relative blood redistribution: bimodal ventilation/ 
perfusion distribution: physiological shunt. 














LIST OF VARTARig, AND UNITS 















solubility of oxygen in blood 
arterial/alveolar oxygen tension ratio. 
arterial carbon dioxide content 
(compartment i) 
arterial gas content 
arterial nitrogen content (compartment i) 
ideal arterial carbon dioxide content 
ideal arterial nitrogen content 
ideal arterial oxygen content 
arterial oxygen content (compartment i) 
carbon dioxide blood content 
dynamic compliance 
gas content in blood 
ideal blood gas content 
blood nitrogen content 
cardiac output 
blood oxygen content 
static compliance 
mixed venous carbon dioxide content 
(compartment i) 
mixed venous gas content 
mixed venous nitrogen content 
mixed venous oxygen content 
diffusion constant 
Staverman reflection coefficient 
amount by which the P50 (at 37°c; pH= 
7,4; PC02 = 40 mmHg) of the subject's 
blood exceeds the standard of 26,8 mrnHg. 
ratio 
ml N2/100 ml blood 
ml N2/l(X) ml blood 
ml m2/100 ml blood 
ml N2/l(X) ml blood 
ml 02/100 ml blood 
ml 02/l(X) ml blood 
ml C02/100 ml blood 
ml/an H20 
ml gas/100 ml blood 
ml gas/100 ml blood 
ml N2/100 ml blood 
1/min 
ml 02/100 ml blood 
ml/an H20 
ml m2/100 ml blood 
ml gas/100 ml blood 
ml N2/100 ml blood 
ml 02/100 ml blood 












fraction of alveolar carbon dioxide con-
centration (compartment i) fraction 
fraction of alveolar gas concentration fraction 
fraction of alveolar nitrogen concentra-
tion (compartment i) fraction 
fraction of alveolar oxygen concentration 
(canpartment i) fraction 
volumetric fraction of gas fraction 
fraction of inspired carbon dioxide concen-
tration fraction 
fraction of inspired gas concentration fraction 
fraction of inspired nitrogen concentra-
tion fraction 
fraction of inspired oxygen concentration fraction 
functional residual capacity 1 
capillary oncotic pressure nmHg 
interstitial oncotic pressure rnmHg 
haemoglobin concentration g/100 ml blood 
arterial haemoglobin concentration g/100 ml blcxxi 
percentage of total pulmonary capillary 
perfusion to the high VA/Q region % 
venous haemoglobin concentration g/100 ml blood 
bicarbonate concentration nM/l 
haematocrit % 
arterial haematocrit % 
venous haematocrit % 
net volume (fluid) flow 1/min 
filtration coefficient 1/min - mmHg 
percentage of total pulmonary capillary 











the mean VA/Q ratio of the mode with the 
lesser mean in a bimodal ventilation/ 
perfusion distribution. 
log mean flow/unit volume 
alveolar - arterial oxygen tension dif-
ference 
alveolar carbon dioxide partial pressure 
arterial carbon dioxide partial pressure 
arterial carbon dioxide partial pressure 
(compartment i) 
alveolar gas partial pressure 
arterial nitrogen partial pressure 
arterial nitrogen partial pressure 
( com part men t i) 
alveolar nitrogen partial pressure 
alveolar oxygen partial pressure 
arterial oxygen partial pressure 
arterial oxygen partial pressure 
(compartment i) 
barometric pressure (atmospheric) 
pulmonary microvascular pressure 
carbon dioxide partial pressure 
positive end expiratory pressure 
effective inspired gas pressure 
gas partial pressure 
acid base indicator 
vapour pressure at body temperature 
interstitial pressure 
ideal carbon dioxide partial pressure 
nitrogen partial pressure 
Units 
ratio 






































oxygen partial pressure 
virtual oxygen partial pressure 
mixed venous carbon dioxide partial 
pressure 
mixed venous nitrogen partial pressure 
mixed venous oxygen partial pressure 
total pulmonary capillary perfusion 







log standard deviation of flow/unit volume 
haemoglobin oxygen saturation 
solubility of carbon dioxide in blood 
solubility of nitrogen in blood 
solubility of oxygen in blood 
blood temperature 
total lung capacity 
alveolar ventilation 
total inspired alveolar ventilation 
total inspired alveolar ventilation for 
compartment i 
vital capacity 

















ml 02/100 ml blood -
mmHg 
ml N2/100 ml blood -
rrmHg 










Variable Description Units 
------------------------------------------------
Yi 
anatanical dead space 
alveolar dead space 
physiological dead space 
nitrogen exchange in the lung 
oxygen consumption (supply) 
tidal volume 
total ventilation (minute volume) 
log flow/unit volume in a compartment 













The management of patients suffering from the adult respiratory distress 
syndrome (ARDS) presents a particularly difficult problem, as far as the 
assessment of the haemodynamic status and underlying patho-physiology are 
concerned. Patients susceptible to ARDS often present with acceptable 
blood gas measurements (a primary diagnostic aid in ARDS) and then sud-
denly (over as short a period as two hours), deteriorate to dangerously 
low blood oxygen tension levels; these patients then have to receive 
emergency treatment (i.e. ventilator and volumetric therapy) with con-
comitant risks. 
The multiplicity of interrelated physiological variables involved (all 
affecting the status of the patient to a lesser or greater extent) are 
often confusing and could even be misleading in the process of clinical 
decision-making. Conventional methods of assessing patients sometimes 
prove to be inadequate, since these methods do not take into account that 
the syndrome is a complex interplay amongst several multivariate physio-
logical variables - this is left to the good judgement of the experienced 
clinician. 
The concept of systems physiology (i.e. the interrelating of a multitude 
of interdependent physiological variables) is already well established, 
especially in those fields where fundamental research has been under-
taken. Systems analysis, applied to physiological processes, emphasises 
the importance of the interdependency between variables and their rela-
tion to each other; it therefore analyses the system as a whole, rather 
than paying attention to a few important, but isolated, variables. 
Modelled on a computer, the processes are translated into a mathematical 
model of the preferred level of sophistication. Supplied with the neces-
sary input variables, the model can simulate and actually predict various 
clinical conditions in the patient. The application of computer model-
ling to the actual process of clinical decision-making is, however, still 
a research modality and not readily applied; it can probably be ascribed 
to the complexity of most real life clinical situations. It is the 
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objective of this thesis to demonstrate how computer modelling may be 
applied to the management of patients susceptible to, and suffering from, 
ARDS. 
The background respiratory physiology and patho-physiology of the syn-
drome is discussed, followed by the philosophy of systems physiology and 
computer modelling. The development of a computer model (based on equa-
tions used previously by another researcher) is explained, followed by 
the simulation of hypothetical conditions in the patient. It is then 
demonstrated how the model could be used as an aid in assessing the 
status of the patient. 
The thesis is concluded with the extraction and definition of a 
diagnostic index, based on the simulation results produced by the model, 
which can be applied with relative ease to identify patients susceptible 
to the ARDS syndrome or any other patient suffering from 
ventilation/perfusion distribution abnormalities. 
The thesis is aimed at both the engineering and medical professions, 
since it incorporates aspects from both these disciplines. It has the 
unfortunate disadvantage though that the reader may find some sections 
rather trivial and others lacking the necessary explanation, depending in 
which profession he received his training. It is nevertheless believed 
that al though the concepts presented transcend the respective discip-
lines, it will be of benefit to both and may, in future, lead to closer 





The adult respiratory distress syndrome (ARDS) was first described as a 
clinical syndrome in 1967 and since then extensive research has been 
undertaken worldwide as evidenced by literature. This survey is biased 
towards those articles of a mathematical or quantitative nature, particu-
larly those emphasizing the role of measurable physiological variables 
and their interrelationships pertaining to the cardio-respiratory system. 
An historical perspective of ARDS was sketched in a recent review by 
Petty (1982) who is considered to be an expert on ARDS. ARDS was first 
described as a clinical syndrome by Ashbaugh et al. (1967). The patholo-
gical picture was almost identical to the infantile respiratory distress 
syndrome and was one of the major reasons why the term adult respiratory 
distress syndrome (ARDS) was suggested by Petty and Ashbaugh (1971). 
Despite the fact that ARDS was described several years ago, neither the 
mechanism nor an established marker of the syndrome is known. The adult 
respiratory distress syndrome is the final common pathway of a variety of 
apparently unrelated but massive insults to the lung. 
Petty and Fowler (1982) defined the criteria for diagnosis (which should 
be followed closely to prevent confusion with other acute respiratory 
diseases) and general principles of management, emphasizing the fact that 
no firmly established mechanism or common factor has been established as 
the common pathway. Although extensive work has been done, to date the 
solution, if any, is still evading us, as will be discussed in this 
review. 
2.2 PATHOPHYSIOUXiY 
2.2.1 General: The mechanism and consequences of pulmonary oedema were eva-
luated by Ayres (1982), who distinguished between the syndromes of car-
diac lung, shock lung (ARDS) and elaborated the ventilatory principles of 
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shock lung. The cardiac lung; increased lung water due to left ventricu-
lar (LV) malfunction, is primarily related to an increase in LA hydrosta-
tic back-pressure and can be considered a reflection of diffuse 
interstitial and alveolar transudation. The Shock lung syndrome is an 
example of interstitial and alveolar exudation, primarily due to changes 
in osmotic pressure and capillary permeability and occurs with normal 
left atrial (LA) pressure. In an experimental study, Lamy et al. (1976) 
classified patients on the basis of physiological criteria and correlated 
them with open lung biopsies and autopsy material. This experimental 
study is unique and provides useful information as regards lung patho-
logy. Patients were divided into three groups depending on the arterial 
oxygen partial pressure (Pa02) and response to venilatory therapy. They 
demonstrated that interstitial fibrosis is not necessarily progressive, 
may possibly be reversible and that the point between reversibility and 
irreversibility is unknown; one important aetiological factor may be 
oxygen (02) exposure at high concentration. 
It is generally accepted that surfactant plays a key role in the bio-
chemical pathophysiology of the disease; its relation to lung dynamics 
has been reviewed in greater detail under a subsequent heading. 
A definite correlation between surfactant and alveolar permeability with 
subsequent changes in compliance has been demonstrated by Dauberschmidt 
et al. (1982) in their animal models. The major pathophysiologic mecha-
nism now considered in human ARDS is an increased permeability of the 
alveolar wall, related to endothelial and epithelial damage. Ideally, 
treatment should also include pharmacological substances which influence 
the excretion of phospholipids in the alveolar wall. 
The conversion of angiotensin is one of the major endothelial functions. 
It therefore seems likely that this function could be impaired in ARDS, 
so that the activity of angiotensin converting enzyme (ACE) could be an 
index of the extent of endothelial damage. In a recent report on its 
diagnostic significance in pulmonary disease (Hollinger, 1983), it ap-
pears possible that a lowered serum level of ACE may prove to have 
clinical significance. Fourier et al. (1983) prospectively studied ACE 
levels in 36 patients with ARDS and it was found that the variations of 
ACE levels had no prognostic value except in aseptic ARDS, where lower 
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levels are associated with a higher mortality. 
Lamy et al. (1983) demonstrated the participation of the complement -
leukocyte cascade in the increased pulmonary capillary permeability asso-
ciated with ARDS. 
2.2.2 Cardio-respira tory disorders: Jardin et al. (1979a) focussed on the 
pulmonary and systemic haemodynamic disorders in ARDS. Their measure-
ments pointed out that pulmonary hypertension is a usual finding in ARDS 
and there is an associated increase in patients who died. They suggested 
the hypovolemia should be corrected despite the presence of pulmonary 
oedema. 
More recently biventricular function was examined by Sibbald et al. 
(1983) in patients suffering from ARDS; the complex interrelationship 
between the various cardiac ejection fractions and arterial pressures 
were analysed by a combination of invasively determined pressures and 
concomitant radionuclide angiography. 
The complex interplay between right and left ventricular function in ARDS 
and the effective treatment of the patient require a thorough understan-
ding of the perplexing haemodynamic adjustments to acute illness. Laver 
et al. (1979) suggested that the ventricles should be viewed as if opera-
ting in parallel as well as in series; careful thought should be given 
when therapy is guided according to the Frank-Starling relationship. 
Czer et al. (1980) and Shoemaker et al. (1980) analysed, in a 
retrospective study on sixty patients with sustained ARDS, the cardio-
respiratory factors preceding and following the development of ARDS. 
They suggested that volume therapy, if at all, should be instituted early 
in the course of ARDS and therapy should be directed to an appropriate 
goal, which is not the attainment of normal values but that compensated 
state which affords the best possible chance of survival. A series of 
comprehensive measurements and statistical analysis is presented; the 
repeatability of which is rather doubtful. 
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2.3 PATIENT MONITORING AND CARDIO-RESPIRATORY MEASUREMENTS 
2.3.1 Monitoring: Close monitoring of the patients with ARDS is useful and 
often essential for diagnostic and therapeutic reasons. 
A comprehensive and up-to-date discussion on haemodynamic monitoring 
techniques is presented by Boysen (1982), describing techniques to mea-
sure cardiac output, mixed venous blood and the interdependence of 
posi ti ve-end-expira tory-pressure (PEEP), cardiac output (CO) and pul-
monary wedge pressure (PWP). The response to therapy should be monitored 
continuously so that cardio-pulmonary function can be dynamically opti-
mized. 
Respiratory principles and techniques were discussed on a similar basis 
by Fallat (1982). Lung mechanics and gas exchange parameters are among 
the most prominent diagnostic aids, facilitating early treatment of the 
high risk patient and optimization of ventilation procedures. 
A more general, although detailed, approach towards patient monitoring is 
suggested by Bone (1981), stressing the importance of intelligent obser-
vation in conjunction with the measurement of various physiological 
variables. The most important parameters that should be considered are: 
body weight, urine analysis, radiologic examination, electro-cardiogram 
(ECG), haematocrit and haemoglobin, arterial blood gases, variables re-
lated to gas volume and bedside measurement of lung mechanics. 
A study conducted by Covelli et al. (1983) supports the use of the 
arterial-oxygen-to-inspired-oxygen concentration ratio (Pa02/FI02) as an 
accurate reflection of the physiological shunt (Qsp/Qt) in patients with 
ARDS; it may be used to predict the need for continuous positive airway 
pressure (CPAP) therapy as well as serve as a guideline for further 
modifying. 
Shoemaker et al. (1979a) evaluated the biological imp:::>rtance of various 
haemodynamic and oxygen transport variables in post-operative patients. 
The analysis is based on a series of experiments conducted on post-
operative patients in order to establish monitoring goals and quantita-
tive therapeutic indices as guides to therapy (Schoemaker et .al., 1979b; 
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Schoemaker et al., 1979c; Bland et al., 1978). A very interesting ap-
proach was followed and justifies future validation of proposed tech-
niques in subsequent research projects. 
Cbmputer based patient monitoring will play an ever increasing role in 
future, providing unlimited possibilities in patient management. Prakash 
et al. (1982) described such a system with samples of application pro-
grams and the possibility for closed-loop control of mechanical ventila-
tion. 
2.3.2 Measurements: In order to monitor the patient, measuring equipment in 
conjunction with specialized transducers is utilized. Like any other 
form of measurement, these are susceptible to human error and technical 
limitations . 
Pitfalls of Swan-Ganz catheterization (Backhyo et al., 1975; Backhyo et 
al., 1977), errors in sampling pulmonary arterial blood (Shapiro et al., 
1974) and other measurement-related problems are all factors which may 
influence the final results. 
It is unlikely that even under optimal conditions, an accuracy of more 
than ninety percent will be acquired with the thermcx:iilution technique 
for measurement of cardiac output (Weil, 1977). Weisel et al. (1975) 
discussed the theory, technique and experimental validations of 
thermodilution cardiac output measurements in a review. 
In a recent article (Stetz et al, 1982), the reproducibility and accuracy 
of the thermcx:iilution (TD) methcx:i in the clinical setting has been inves-
tigated. It was shown that a minimal change of twenty-two percent is 
required for a single TD measurement to be clinically significant. 
The effects of mechanical ventilation on the measurement of CO by TD 
have been investigated by Snyder and Powner (1982); they suggested the CD 
is best approximated by the means of values taken at regularly spaced 
intervals throughout the ventilation cycle. 
Interpretation of pulmonary-artery wedge pressure (PAWP) when PEEP is 
used, has not been resolved (Roy et al., 1977; Geer, 1977; Miller, 1982). 
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The positioning of the tip of the Swan-Ganz catheter definitely plays a 
major role in this respect; temporary simultaneous discontinua t1on of 
PEEP should be considered as a possibility to solve the dilemma. 
2.4 PATIENT MANAGEMENT 
2.4.1 General: An integrated approach to the ARDS patient is advocated by 
Clemmer and Orme (1982), emphasizing the importance of a team approach 
consisting of specialised groups in order to integrate information into 
therapeutic decisions which best serve the patient as a whole. Rigid 
protocols and communication procedures should be established because of 
the complexity of the illness and the therapies administrated. 
Boutros et al. (1977) compiled an algorithm for management of pulmonary 
complications in burn patients; the basic structure of which could be 
followed with adaptions in the case of ARDS patients. 
Management of patients with septic shock is very difficult when acute 
respiratory failure is also present, Jardin et al. (1979b) studied the 
effects of blood volume expansion, dopamine infusion and isoproterenol 
infusion on blood gases in hypoxemic patients suffering from septic 
shock. These agents improved systemic oxygen transport al though Pao2 . . 
decreased slightly due to an increase in Qsp/Qt. 
Bone (1978) evaluated the prolonged effects of diuresis and PEEP ad-
ministrated throughout the course of respiratory failure. Beneficial 
effects of treatment with albumin and diuretics were transient and 
multiple doses were required to sustain the effects; he emphasized the 
importance of a randomised collaborative study to evaluate treatment 
protocols in ARDS patients. 
Wood and Prewitt (1981) reviewed evidence concerning the interrelation-
ships among pulmonary oedema formation, pulmonary blood flow distribution 
and how these relationships are altered by ventilator and vaso-active 
drug therapy. 
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2.4.2 Ventilatory support: The hypoxemia accompanying ARDS, may be signifi-
cantly improved with sustained application of a modified form of spon-
taneous or mechanical ventilation. To date, PEEP in its various forms 
represents the most effective, but not ideal, means of treatment. 
The application of the various ventila tory models and a comprehensive 
review on PEEP, with its cardiovascular effects, has been presented by 
Gong (1982). It provides a clear and instructive source of information 
for anybody interested in ventilation and its potential complications. 
Al though exact mechanisms are not completely understood, it definitely 
decreases morbidity and mortality in patients who are hypoxemic. Sur-
vival appears related more to the maintenance of adequate tissue oxygena-
tion, as manifested by high mixed venous oxygen, than to improved gas 
exchange, as reflected by an increase in Pao2 (Springer and Stevens, 
1979). 
2.4.2.1 Cardiac effects of PEEP: A reduction of cardiac output tends to 
occur proportionally to increments of PEEP and is generally most marked 
with PEEP> 10 cmH2o. However, the magnitude of the effect varies from 
individual to individual and results from a complex balance among several 
factors: the status of the cardiovascular system and intravascular 
volume, the compliance of the lung and the functional residual capacity 
at the time PEEP is applied. 
Despite the widespread use of PEEP in patients with ARDS, the 
cardiovascular mechanisms that decrease cardiac output are not well 
understood. Jardin et al. (1981) studied the effects of a stepwise 
increase in PEEP and found that levels above 10 cmH20 resulted in a 
decreased cardiac output mediated by a leftward displacement of the 
interventricular septum, which restricts left ventricular filling. 
Cassidy et al. (1981) suggested that ventilation with increasing levels 
of PEEP may cause an inhibition of cardiovascular regulatory centres in 
the central nervous system in addition to the direct mechanical effects, 
and that the inability to compensate constitutes an important cause of 
reduced CD. 
In an extensive review Pick et al. (1982) favour an impedance to systemic 
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venous return as the major factor in decreasing CO. Additional direct 
reduction of left ventricular function at high levels of PEEP is secon-
dary to geometric changes that cause a decrease in compliance. Neural 
and humeral mechanisms may be operative and endocardial ischaemia at high 
levels of PEEP may also be a contributing cause of CD depression. 
Ellman and 1)3mbin (1982) reported in a study the lack of adverse haemo-
dynamic effects of PEEP. The mean fall of the cardiac index (CI) was 
only 6% for levels of PEEP up to 20 cmH2o. They believe it may be due to 
the avoidance of hypovolemia, limited use of sedative and paralytic drugs 
and the use of intermittent mandatory ventilation (IMV). 
It was shown by Perschau et al. (1979) that PEEP promptly reduces CO 
during spontaneous ventilation, related to a decrease in pulmonary flow 
in expiration; this has a very important bearing on CO determined by 
indicator dilution methods, since a fundamental assumption of these 
techniques of measuring flow in the circulation is consistency of blood 
flow. 
In a comparative study of the cardio-respiratory effects of continuous 
positive airway pressure (CPAP) and controlled positive pressure ventila-
tion (CPPV) in ARDS by Simonneau et al. (1982), it was found that PEEP 
has different haemodynamic effects using these two modes; cardiac output 
is largely decreased with CPPV, but remains relatively constant when the 
CPAP or IMV mode is maintained. 
2.4.2.2 Optimal PEEP: It is possible to counteract the adverse effects 
of PEEP on cardiac output with the institution of fluid therapy and 
inotropic drugs, which suggests the existence of an "optimal" combination 
between PEEP and haemodynamic status. 
Suter et al. (1975) indicated in a study of normovolemic patients 
suffering from ARDS that maximum oxygen transport (CD X arterial oxygen 
content) correlated with the greatest total static compliance. They 
defined ''best PEEP" and suggested that in normovolemic patients maximum 
total static compliance could be used as an indicator for the best gas 
exchange. (It resulted in settings of approximately 15 cm H20.) 
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Civetta et al. (1975) defined "optimal PEEP" as that value where the 
intrapulmonary shunt is minimised. Interventions, such as volume expan-
sion and employment of inotropic agents were frequently used to counter-
act adverse cardiovascular effects. In some patients PEEP levels of up 
to 35 cm H20 were employed. 
Demers et al. (1977) defined an "optimal PEEP" as that value where the 
maximum mixed venous oxygen tension (Pv0 2) is reached. In his opinion 
the oxygen transport does not reveal information about the oxygen demand; 
whereas Pvo2 gives a direct indication of tissue oxygenation. 
Gallagher et al. (1978) confirmed the definition by Civetta and stressed 
the fact that if goal-directed therapy (shunt reduction to 15% or eleva-
tion of Pa02/FI02 to 300 with cardio-vascular intervention) is instituted 
early in the course of disease, levels of higher than 15 cm H20 are 
seldomly used. 
Venus et al. (1979) determined whether an optimal level of CPAP could be 
applied as an effective and safe method for treatment. PEEP was in-
creased in conjunction with the infusion of fluid until the cardio-
vascular system showed signs of depression, at which level it was even-
tually maintained. They again emphasized the imJX)rtance of CPAP therapy 
in the early stages of ARDS. 
Walkinshaw and Shoemaker (1980) defined the "optimal PEEP" to occur at a . 
level where the maximum oxygen consumption, vo2 = (arterial oxygen 
content - mixed venous oxygen content) X CI X 10, occurs without a 
significant increase of the interpulmonary shunt. They found it to be at 
levels of 10 cm H2o without volume load, at levels of 15 cm H20 with 
volume load (albumin was administered). They suggested that optimal PEEP 
must be determined in relation to optimal volume, flow and oxygen trans-
port. 
Nelson et al. (1982) investigated the effect of PEEP on oxygen consump-
tion (V02) in dogs. They found that vo2 does not correlate with changes 
in lung compliance or shunt fraction and also suggested that increased 
oxygen extraction comes into play as a compensatory mechanism to sustain 
vo2 as long as JX)ssible. 
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2.4.2.3 High frequency ventilation: The present status of high frequen-
cy ventilation (HFV) and future directions of research in this field were 
evaluated by Gallagher et al. (1982). Controlled studies of HFV and 
conventional techniques during ARDS are still required before any real 
answers are forthcoming; accompanied with standardization of delivery 
systems and a study of the potential detrimental aspects of HFV. 
2.5 VENTILATION AND PERFUSION RELATIONSHIPS IN THE LUNG 
2.5.1 Introduction: The concept of "ideal" alveolar air and the analysis of 
ventilation perfusion relationships in the lungs were first introduced by 
Riley and Cournand (1949). They derived the equations for the 
respiratory quotients and also the ratio of the alveolar ventilation to 
alveolar perfusion. A graphical solution to the "ideal alveolar air" 
equations with the aid of respiratory quotients lines on a PCD2/F02 graph 
was demonstrated - presently the equations are solved by numerical 
techniques on the computer; the principles however remained unchanged. 
In 1955 Farhi and Rahn investigated the various factors influencing the 
ventilation-perfusion ratio (VA/Q) distribution in the lung. He con-
cluded the alveolar-arterial o2 difference can be attributed to three 
independent phenomena; diffusion impairment, venous admixture and unequal 
ventilation-perfusion ratios among the alveoli. 
Professors J.B. West and P.O. Wagner, attached to the Department of 
Medicine at the University of California, are considered to be 
international authorities on all aspects related to ventilation -
perfusion relationships. 
A comprehensive and most instructive article was presented by West 
(1977), discussing the state-of-the-art in ventilation-perfusion rela-
tionships. The partial oxygen pressure (P02), partial carbon dioxide 
pressure (PCD2) and partial nitrogen pressure (PN2) in any gas-exchanging 
unit of the lung are uniquely determined by three major factors; the 
ventilation-perfusion ratio, the composition of inspired gas and the 
composition of mixed venous blood; illustrating the importance of the 
VA/Q factor. 
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A new approach towards the study of blood gas exchange in the lung was 
followed by King and Briscoe (1967); namely the construction of Bohr 
integral isopleths and ventilation-perfusion ratio isopleths superimposed 
on the oxygen dissociation curve. Several useful insights on oxygen 
transfer in the lungs are afforded by the use of these isopleths; it is 
however a relatively complex procedure and could be confusing if the user 
is not thoroughly acquainted with the method. 
2.5.2 Special Conditions: Evans et al (1974) defined the properties which a 
gas must have for it to be possible for ventilation-perfusion inequality 
to enhance pulmonary elimination or uptake; this condition is however not 
met for any known gas under physiological steady-state conditions. It 
follows that any mismatching of ventilation or blood flow must reduce 
pulmonary elimination or uptake of any gas with a linear dissociation 
curve (carbon dioxide has an almost linear relationship). 
Colburn et al. (1974) compared the gas exchange of a lung model with an 
arbitrary mismatching of blood flow and ventilation to the gas exchange 
of a homogenous lung with the same flow; it proved to be a function of 
the solubility of the gas. 
The gas exchange behaviour of distributions of ventilation-perfusion 
ratios is elucidated in a discussion by West et al. (1974); they 
introduced another approach to gas exchange in the presence of inequality 
based on a pressure-solubility diagram. 
When the inspired ventilation-perfusion ratio of a lung unit is gradually 
reduced, a point is reached where the expired ventilation falls to zero, 
such a unit will no longer eliminate gas but may continue gas uptake 
unless it becomes atelectatic; Dantzker et al. (1975) presented a 
theoretical analysis of the factors involved under these conditions. 
The effect of local pulmonary blood flow control by local alveolar o2 
tension on steady-state overall pulmonary gas exchange was analysed by 
Grant (1982) with techniques derived from control theory. This approach 
lends itself to computer simulations pertaining to the ventilation-
perfusion distributions in the lung and could add to the actual "physio-
logical credibility" of such a model. 
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2.5.3 Estimation and evaluation of ventilation-perfusion ratios: A major 
descriptive problem exists in the presentation of the VA/Q distribution; 
the problem is how to handle properly multiple gas data so as to gain the 
greatest amount of insight into the properties of V A/Q distributions, 
without overstepping the theoretical limitations inherent in the particu-
lar technique and without discarding useful information. 
A general approach to the evaluation of VA/Q ratios in normal and 
abnormal lungs was discussed by Wagner in his paper (1977). The 
theoretical limits and probabilistic descriptions relating to the VA/Q 
distributions were discussed by Evans and Wagner in a subsequent paper 
(1977), including an illustrative graphical approach. 
The estimation of distributions of VA/Q ratios (Wagner, 1981) is a 
numerically complex procedure with inherent limitations and associated 
"sampling" problems; Wagner is considered to be the world leader on the 
theoretical implications of the estimation of continuous distributions of 
VA/Q ratios. 
2.5.4 Experimental Investigations: Briscoe et al. (1960) assessed the dis-
tributions of ventilation within the lungs by a nitrogen washout and 
washin technique. They noted that when oxygen is breathed the arterial 
oxygen saturation rises rapidly and when after 15 minutes of o2 brea t-
hing, air is given, the saturation falls slowly. 
West et al. (1964) measured in vitro the distribution of blood flow in a 
dog's lung with xe133; the distribution was investigated as a function of 
vascular and alveolar pressures. 
Lenfant and Okubo (1968) determined the pulmonary blood flow in healthy 
subjects and patients suffering from diffuse obstructive pulmonary syn-
drome based on a method whereby the F 1o2 was increased and blood gases 
monitored with short intervals. These data, combined with the distribu-
tion function of lung volume determined by lung N2 washout (Okubo and 
Lenfant, 1968), led to the construction of the continuous distribution 
of blood flow and lung volume as a function of VA/Q. 
Wagner (1972) described the multiple inert gas elimination technique, in 
which the distribution of V A/Q could be measured virtually as a 
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continuous function under steady state conditions. This technique was 
applied to determine the distribution of VA/Qin dogs and a few patients 
suffering from acute respiratory failure (Wagner et al., 1974). 
Dantzker et al. (1979) determined the distribution of ventilation-
perfusion ratio by the multiple inert gas elimination technique in 
sixteen patients with ARDS. In each case the distribution was bimodal; 
furthermore they concluded the hypoxemia is caused by the presence of 
shunts or units of very low ratio of ventilation to perfusion. 
2.6 GAS EXCHANGE IN THE LUNGS 
2.6.1 Introduction: West (1971) studied pulmonary gas exchange in computer 
models containing series inequality of ventilation; it was found that a 
lung region which inspires gas from an adjacent region usually has a high 
alveolar PCD2 and a grossly impaired CO2 output; its o2 uptake is much 
less affected. 
The alveolar/arterial oxygen tension difference P(A-a)02 is extensively 
applied as an index of gas exchange; it reflects the effects of the 
diffusion gradient, ventilation-perfusion imbalance and true shunt. 
· Unfortunately the difference is sensitive to changes in the Fio2. 
Gilbert (1974) suggested another way of expressing the difference between 
alveolar and arterial oxygen partial pressures, namely the 
arterial/alveolar oxygen tension ratio (a/AP02); it proved to be more 
stable with changing values of Fr02. 
Piiper and Scheid (1982) presented mode+s for a comparative functional 
analysis of gas exchange organs in vertebrates. They followed · an 
interesting "lateral" approach towards a better understanding of the 
underlying gas exchange principles in biological systems. 
2.6.2 Gas transfer in ARDS: The rise in F02 in response to graded increases 
in FI02 in dogs before and after the creation of a shunt was studied by 
King et al. (1974). They concluded that patients with shock lung do not 
necessarily need to have shunting and that hypoxemia may be ascribed to 
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areas with a very low diffusing capacity; a finding which has some very 
imJX)rtant therapeutic and prognostic implications. It followed out of a 
discussion held on this article that there might still be some confusion 
as regards the exact definition of the term "shunt". 
The relationship between delivery and uptake of o2 was evaluated in 
twenty patients with ARDS by Danek et al. (1980). They concluded that in 
patients with ARDS there is a direct relationship between delivery of o2 
and uptake of o2. Changes in Pi02 may not reflect changes in o2 
delivery, cardiac output or the adequacy of tissue oxygenation. 
Ralph and Robertson (1981) examined the physiologic abnormalities in ARDS 
gas exchange and how it may be related to the observed pathologic 
changes. They concluded that increased shunt is the predominant 
mechanism of arterial hypoxemia; many patients may also have low V A/Q 
regions, although these may not be apparent clinically if a high F1o2 is 
used. A definite pathologic correlate of the regions of low ventilation 
to perfusion has not been determined; furthermore the pathology could not 
be predicted by any single physiological test, but the information ob-
tained by altering the F 1o2 or PEEP level could be used to predict the 
predominant underlying pathology. 
In an extensive review published by Dantzker (1982) the following facts 
concerning gas exchange in the ARDS emerged: 
(a) The acute abnormalities of pulmonary function, in all cases, result 
from the progressive accumulation of extravascular fluid in the 
lung. 
(b) The progression of events is similar irrespective of the aetiology 
of the oedema, be it increased hydrostatic presstire or increased 
capillary permeability. 
(c) Flooded alveoli are scattered throughout the lung, with filled 
alveoli lying adjacent to uninvolved ones. 
(d) Hypoxemia of ARDS is primarily due to pulmonary oedema which results 
in a right to left shunt. 
(e) In addition, hypoxemia may be caused by the presence of regions with 
very low (0,02 - 0,1) ventilation-perfusion ratios as well as the 
possibility of diffusion abnormality; this has however been ruled 
out by experiments performed by Dantzker. 
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They applied the technique of multiple inert gas estimation to evaluate 
abnormalities of gas exchange and it was found that while units with very 
low ventilation-perfusion ratios do sometimes exist; no diffusion impair-
ment could be detected. 
It followed, from results, that in ARDS, blood flow is distributed mainly 
to two types of lung units; those normally ventilated and those unventi-
lated. Any diffusion impairment which may have been induced by the 
pulmonary oedema did not appear to contribute significantly to the deve-
lopment of hypoxemia. 
The finding in some patients that a significant rise in Pa.02 may be seen 
as the FI02 is increased, was explained by intermittent ventilation of 
some flooded alveoli leading to the presence of lung units with very low 
but finite VA/Q ratios. 
Finally, it should be noted that alterations of non-pulmonary variables 
(PvD2, CD, anaemia, increased metabolic rate) can dramatically alter the 
arterial blood gases; it is possible to misinterpret a fall in Pa.02 due 
to one of these factors as a worsening of the underlying ARDS. 
2.7 LUNG MECHANICS 
2.7.1 Surfactant and Compliance: The mechanical properties of the lung, 
especially the compliance and accompanying surface tensions in the al-
veoli, are of great relevance in the pathogenesis of ARDS. It is a 
generally accepted fact that a definite correlation exists between the 
decrease in lung compliance and the 01 set of ARDS (Bone, 1976a, 1976b; 
Petty et al., 1979). 
Bone (1976a) introduced a method based on lung compliance for a simple 
non-invasive determination that assists in the evaluation of acute res-
piratory failure, it basically involves the evaluation of the pressure-
volume curves and associated "shifts" that occur. 
In a prospective study by Bone (1976b) of the value of pressure-volume 
curves· in seven patients suffering from acute respiratory failure; the 
following facts emerged: those conditions associated with predominantly 
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airway disease altered dynamic compliance measurements, whereas those 
associated with loss of lung volume generally altered both dynamic and 
static pressure-volume measurements. 
Petty et al. (1977) studied the characteristics of pulmonary surfactant 
in one patient suffering from ARDS and concluded that definite biochemi-
cal changes took place in the surfactant layer, associated with an irre-
versible loss of surface elasticity. They suggested that the rheologic 
and kinetic properties of pulmonary surfactant may be more relevant to 
physiologic function than the absolute value of compliance. 
In a subsequent study, Petty et al. (1979) examined lungs from five 
patients who died with ARDS. The alveoli displayed increased surface 
compressibility which they considered to be the primary factor 
contributing to the stiffness of the lungs of ARDS patients. 
Massaro et al. (1980) suggested that a physical alteration in surfactant 
may lead to, or contribute to, the development of some forms of ARDS. 
They hypothesized that shallow breathing leads to the aggregation of 
surfactant into a less functional form resulting in increased alveolar 
surface tension and atelectasis. The increase in surface tension would 
also contribute to the oedema found in these conditions. This is an 
interesting hypothesis and surely justifies further experimental investi-
gation. 
2.7.2 Pulmonary Oedema: Staub et al. (1967) induced pulmonary oedema in 
anaesthetized dogs by transfusion of dextran and alloxan, followed by 
extensive cardio-pulmonary monitoring to ascertain the sequence of fluid 
accumulation in lungs. They found the mechanisms of oedema in the two 
groups to be different; fluid appears first in the interstitial connec-
tive tissue around the large blood vessels and airways, followed by 
independent and rapid alveolar filling after the interstitial compart-
ment is well filled. 
An extensive review covering the subject of pulmonary oedema was 
presented by Staub (1974) and is probably the most comprehensive report 
on this subject. 
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The possibility that surface tension may effect the hydros ta tic 
transmural pressure of pulmonary vessels and the development of pulmonary 
oedema was studied by Albert et al. (1979) in anaesthetized dogs. They 
concluded that increased surface tension favours fluid leakage, 
presumably because it increases the microvascular transmural pressure. 
The Starling equation relates the hydrostatic forces and colloid oncotic 
pressures to the net volume movements across the semi-permeable capillary 
membrane. Civetta (1979) discussed the methodology and limitations be-
hind the application of this equation; it is clearly subject to various 
factors not directly stated in the equation and should, as such, be 
applied with caution. 
It follows that increased alveolar capillary membrane permeability on the 
one hand and changes in the lung alveolar surfactant on the other seem to 
be of great importance in the pathogenesis of ARDS. Kuckelt et al. 
(1981) investigated the validity of a model of ARDS based on repeated 
pulmonary lavage in LEWE-mini-pigs; from their results a primary damage 
of surfactant could be identified. 
A series of experiments in anaesthetised rabbits were conducted by Egan 
(1982), suggesting that hyperinflation of the lung alone could produce a 
protein permeable lung epithelium and accumulation of liquid in the 
alveolar space; the results were however not conclusive. 
Wiener et al. (1983) developed a mathematical model that integrates the 
various processes that affect fluid and protein transport i n the lung. 
The model is useful in following the course of pa t ients with pulmonary 
oedema, and could be a valuable addition t o existing mathematical gas 
exchange models. 
2.8 PRCXiNOSIS AND PREDICTION IN PATIENT MANAGEMENT 
2.8.1 General: Beneken et al. (1979) conducted a survey to elucidate the 
sta te-of-the-art in trend prediction as a basis for optimal therapy, 
emphasizing quantitative prognostic techniques, the detection and use of 
trends in the patients ·state and the use of models in prediction and 
their possible use for deciding which therapy is optimal for a specific 
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patient. An extensive list of centres working in these fields, as well 
as a comprehensive reference list, were included. It serves as a valu-
able review of the various techniques employed and possible applications 
to patients suffering from ARDS. 
In a series of studies by Schoemaker et al. (1973, 1974a, 1974b, 1977) a 
quantitative approach was ·followed towards the early prediction of death 
and survival in post-operative patients suffering from circulatory shock. 
They based their analysis on nonparametric analysis and frequency distri-
butions of cardio-respiratory variables, measured in these patients. 
Usually the objective in therapy of most diseases is to restore normal 
physiological values; they suggested that the bodily response to injury 
and illness are compensatory and have survival value, therapeutic goals 
should rather be directed towards installing cardio-respiratory patterns 
similar to those seen in previous survivors. 
2.8.2 ARDS Patients: Bartlett et al. (1975) suggested a method for retros-
pective and prospective data collection in ARDS patients, based on a 
graph of an alveolar-arterial gradient against time - based on this graph 
he defined a pulmonary insufficiency index which correlated well with 
mortality in the series being investigated (45 patients were evaluated). 
Shimada et al. (1979) selected 14 patients who developed acute hypoxemia 
and monitored pulmonary physiologic values on a daily basis. The data 
was correlated with the progress and prognosis of the ARDS patients. 
They remarked that the method employed by Bartlett et al. (1975) could 
sometimes be misleading, as it represents intrapulmonary shunting or 
ventilation-to-perfusion inequality, which are present in the potentially 
reversible pulmonary pathology of interstitial or alveolar oedema. Com-
bining the alveolar dead space, pulmonary vascular resistance and dynamic 
compliance with the P(A-a)02 serves as a more accurate method for predic-
tion of prognosis. 
A method whereby the arterial oxygen pressure was measured for values of 
40% and 100% FI02 was suggested by Weigelt et al. (1981). By this method 
eighty-two percent of the 22 patients monitored were identified as being 
at risk more than 12 hours before the onset of hypoxemia. 
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A retrospective study was carried out on a group of 50 ARDS patients by 
Jardin et al. (1982) (article in French). The predictive value of a 
severity index (derived from arterial and alveolar oxygenation) was 
tested. 
The diagnostic value of different respiratory function tests in the 
respiratory distress syndrome was investigated by Guillot et al. (1982) 
(article in French); the majority of the measurements consisted of 
expiratory flow variables. 
Fowler et al. (1983) studied 936 patients over a period of 1 year to 
identify predispositions and associated risk in ARDS patients. They 
identified patients who had one or more of eight conditions thought to 
predispose to respiratory failure. It followed that the highest inci-
dence rates occur after direct pulmonary injury such as aspiration of 
gastric contents, rising dramatically when more than one predisposing 
event occurred. This study serves as a valuable measure to select high 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A brief intrcxiuction to respiration physiology is presented in the fol-
lowing chapter, supplemented with a rather philosophical discussion of 
systems physiology and its application to respiration. 
Respiration physiology is a complex and diverse field, impinging on the 
fields of circulation and renal physiology. The objective of this dis-
cussion is not an in-depth analysis of the relevant physiology; instead 
elucidation of the most important issues and their interrelationships has 
been attempted. 
3.1 STRUCTURAL APPROACH 
This section deals with a structural approach towards respiration 
physiology, and the discussion is guided by the anatomical layout of the 
various structures involved in respiration. 
Respiration refers to the complete process of ventilation of the alveoli, 
gas exchange in the lungs, transport of gas towards and from the cells, 
as well as gas exchange on cellular level. The structures involved are 
the airways, lungs, heart, blood vessels and the cells. 
3.1.1 Functional Anatomy: The gas delivery apparatus consists of a collection 
of branching ducts, which finally lead into the alveoli; the area where 
actual gas exchange is effected. 
The trachea, which opens into the larynx, divides into two bronchi, which 
further sub-divide into a system of ducts (transitional zone) leading 
into the alveolar ducts lined with the alveoli (respiratory zone). 
The gas delivery ducts do not partake in the gas exchange process and 
therefore constitute the so called anatomical dead space. (Approximately 
150 ml in the average man of 70 kg.) The concept of an anatomical dead 
space is of relevance when the actual amount of fresh air reaching the 
respiratory zone, i.e. the alveolar ducts lined with alveoli, is calcu-
lated. 
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The alveoli resemble minute bubbles divided by the alveolar septa, 
attached to the alveolar ducts. It is estimated that the respiratory 
zone consists of approximately 300 million alveoli, with an average 
diameter of 0,3 mm. In between the alveoli an intricate network of 
capillaries ensure direct contact of the blood and the alveolar wall; a 
capillary is actually believed to be comprised of a "sheet of blood" 
encapsulated between shared alveolar walls and reinforced by pillar-like 
structures, keeping the walls apart. 
Blood supply to the lung capillaries is sustained through the pulmonary 
artery, which conveys de-oxygenated blood from the right ventricle of the 
heart; the returning oxygenated blood is conveyed through the four main 
pulmonary veins to the left atrium of the heart. A diagrammatic repre-
sentation of the anatomy of the respiratory system is presented in Fig. 
3.1, with the numerical values of a respiratory zone model for an average 
adult in Table 3.1. 
3.1.2 Ventilation: Inspiration is the process of gas delivery from the 
atmosphere to the alveoli; whereas expiration signifies the reverse 
process. Ventilation refers to a combination of these two processes. 
The static volumes involved in the process of breathing (or ventilation) 
are defined as follows: 
Tidal volume (VT) 
Vital capacity (VC) 




RR = Respiration rate 
Normal breathing volume per breath. 
The volume of expired air after a maximal 
inspiration, followed by a maximal expiration. 
The volume of gas that remains in the lungs 
after a maximal expiration. 
The volume of gas that remains in the lungs 
after a normal expiration. 
The total volume leaving the lung each minute. 
















---- PULMONARY VEINS 
Figure 3.1 Diagranmatic representation of the anatany of the 
respiratory system and circulation. 
Component 
Volume of model lung 
Volume of respiratory zone 
Volume of capillary network 
Number of alveoli 
Air-tissue interface 
Tissue-blood interface 
Rad ius of alveolus 
Volume of alveolus 
Surface of alveolus 
Number of capillary segments per 
alveolus 
Capillary blood volume per alveolust 
Capillary surface per alveolust 
Radius of capillary segments 









10.5 . 10- 6 cm3 
30 . 10- 4 cm2 
1800 
4.7 . 10-7 cm3 
28 . 10- 4 cm2 
4 · 10-4 cm 
10.3 . 10-' cm 
Table 3.1 Numerical values of Respiratory Zone (model for average 
adult) - from E.R. Weibel (1963). Morphometry of the 
Human Lung. Academic Press Inc. 
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The various volumes involved in ventilation are exemplified in Fig. 3.2. 
The functional residual capacity is analogous to parallel electrical 
capacitance in the ventilatory system; it damps small and rapid changes 
















Figure 3.2 Lung volumes with typical values for a 




Alveolar ventilation (VA) represents the total amount of new air entering 
. the alveoli each minute. On inspiration, a certain amount of fresh air 
must fill the airways before reaching the alveoli; this volume signifies 
the anatomical dead space (V0). It follows that alveolar ventilation 
equals: 
VA = RR.(VT - Vo) -(3.2) 
A typical value would be: . 
VA = 12 . ( 0, 5 - 0, 15) 
= 4,2 1/min 
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The physiological dead space (V08) represents the total volume of 
inspired air that does not participate in gas exchange; in normal 
subjects it nearly equals the anatomical dead space; however, in the case 
of lung disease it may increase considerably due to abnormalities in the 
alveoli or capillaries. 
Airflow through the airways is a combination between laminar flow (stream 
lines parallel to the sides of the tubes) and turbulent flow. Whether 
local flow will be laminar or turbulent depends to a large extent on the 
Reynolds number (Re). 
Re 
2.r.v.d. = N 
r radius of tube [m] 
V average velocity of medium [ms-1] 
d density of medium [kg.m-3 ] 
N viscosity of medium [Nsm-2 ] 
Turbulence is probable when the Reynolds number exceeds 2000. 
Flow resistance (R) for laminar flow equals: 
1 
R = 8.N.l 
r4 




Note that if the radius is halved, the resistance increases sixteen-fold; 
this is of importance in, for instance asthmatic patients where a nar-
rowing of the airways occurs. The airflow in the bronchi is usually a 
combination of laminar and turbulent profiles. It is furthermore note-
worthy that the chief site of airway resistance occurs at the larger 
airways and not at the narrow alveolar ducts; this is due to the fact 
that the total cross sectional area of the alveolar ducts by far exceeds 
that of the larger airways and because Re never exceeds 2 000 in the 
alveolar ducts. The radius of an alveolar duct is typically 0,1 mm, 
compared to O ,5 mm for a bronchiole; it follows from equation 3.4 the 
ratio of resistance to laminar air flow of an alveolar duct compared to a 
bronchiole is 640 : 1. This implies that the total cross-sectional area 
of the alveolar ducts must be more than 640 times that of the bronchioli. 
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Dalton's Law 
In a mixture of gases the total pressure is equal to the sum of the 
pressures exerted by its component gases; the individual gas pressures 
are referred to as the partial pressures of the comp:>nents. The partial 
pressure of a respiratory gas may be calculated as follows: 
-(3.5) 
PG partial pressure of the gas 
FG volumetric fraction of the gas present in a unit volume 
PEF effective pressure exerted by the gas mixture 
It is imp:>rtant to note that inhaled gas is actually saturated with water 
vapour (also considered as a gas) in the airways; the maximum partial 
pressure of water in a wet gas at a given tem~rature equals the vapour 
pressure of water at that temperature. 
(Vapour pressure at 37°c equals 47 nm Hg.) 
The total pressure (I3.r) exerted by the respiratory gas mixture therefore 
equals: 
-(3.6) 
baranetric pressure (atmospheric) 
water vapour pressure at a specific tem~rature 
Henry's Law 
When a liquid and gas are in equilibrium, the amount of gas in solution 
is directly proportional to the partial pressure of the gas, provided 
temperature is constant. This is of relevance in the case of alveolar 
gas dissolved in capillary blood; it does not, however, account for the 
respiratory gas that is chemically bound to comp:>unds in the blood. 
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Fick's Law 
The rate of transfer of a gas through a sheet of tissue is proportional 
to the tissue area and the difference is gas partial pressure between the 




V gas flow through sheet (1/min] 
D diffusion constant (1/min-m-nmHg] 
A area of sheet [m2 ] 
T thickness of sheet [m] 





The diffusion constant is directly proportional to the solubility of the 
gas in the medium and inversely proportional to the square root of the 
molecular weight of the gas. (CD2 diffuses about 20 times more rapidly 
than o2 through the alveolar septa - it does not, however, imply the 
absence of possible diffusion limitations in the case of CD2 .) 
3.1.3 Elastic Properties of the Lung: The combined elastic properties ~f the 
individual components constituting the lung and thorax are conveniently 
described by a pressure - volume curve. The curve is non-linear with a 
sigmoid shape, it also exhibits hysteresis properties, i.e. the pressure 
- volume relation is different for the inspiration and expiration cycles. 
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Figure 3.3 Representative static volume-pressure relationship 
of lung for a cycle from Oto 30 cm H2o - from 
D.H. Glaister et al. (1973). Bulk elastic proper-
ties of exised lungs and the effect of a transpul-
monary pressure gradient. Resp. Physiol., 17; 
347-364. 
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The slope of the pressure - volume curve, or the volume change per unit 
pressure change, is known as the compliance. If measured at a specific 
volume on a pressure - volume curve, it is referred to as the static 
canpliance (Cs): 
Cs = AVL I APA VL -(3.9) 
A VL change in 1 ung volume [ml] 
A PA change in airway pressure [ cm H2o] 
The dynamic compliance (Cd) can be estimated by taking the ratio of the 
change in lung volume ( A VL) and the change in airway pressure ( .c.PA) at 
zero airflow conditions: 




It is im!X)rtant to note that the compliance as measured in (3.9) and 
(3.10) represents either the lumped thoracic and pulmonary compliance, or 
only that of the lung, depending on which experimental procedure has been 
followed. Furthermore the reader should realise that during inspiration 
a negative pressure is generated within the chest cavity by contraction 
of the respiratory muscles (especially the diaphragm), causing the lung 
to expand by air flowing from a atmospheric pressure to a lower pressure 
in the lungs. This is in contrast with the lungs of a patient connected 
to a ventilator and sealed off from the environment, in which case the 
lungs are distended by the higher pressure generated within the ventila-
tor and air being forced into the airways, resulting in a raised average 
pleural pressure. 
Alveolar surface tension 
Cne of the factors contributing towards the pressure generated within the 
lung when inflated, is that of surface tension in the alveolar wall. The 
fluid lining the alveolar wall generates a tension in the wall, favouring 
total alveolar collapse. If a spherical shape were assumed for a single 
alveolus, the pressure generated within the alveolus can be predicted by 
Laplace's law: 
Pressure = 
4 x surface tension 
alveolar radius -(3.11) 
It is evident from equation (3.11) that an alveolus with a smaller radius 
will generate a higher pressure and therefore attempt to inflate other 
alveoli with a larger radius. According to Laplace's law, the 
collection of alveoli within the lung is a highly unstable system and 
would alternately expand and collapse. In practice this does not, how-
ever, occur and was one of the observations that lead to the discovery of 
surfactant. 
Pulmonary surfactant is a li!X)protein excreted by cells in the alveolar 
wall which dramatically reduces the surface tension in the alveolar wall; 
it also has the effect of making the tension directly dependant on the 
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alveolar surface area. Stability is not perfect and occasionally alveoli 
do collapse (a telectasis); a deep breath will, however, normally re in-
flate collapsed units. 
The preceding discussion is a gross simplification of alveolar stability; 
the factors involved are numerous (mechanical and physiological) and are 
all, by nature, interrelated. 
3.1.4 Transport of respiratory gases 
3.1.4.1 Circulation: The pulmonary circulation begins at the main 
pulmonary artery which receives the mixed venous blood pumped by the 
right ventricle. It sub-divides until it finally supplies the capillary 
bed lining the alveolar walls. The oxygenated blood is collected by the 
small pulmonary veins which eventually unite to form the four pulmonary 
veins which drain into the left atrium. A major pressure difference 
exists between the pulmonary and systemic circulation and consequently in 
the structure of the vessel walls. A comparison of pressures in the two 




Figure 3.4 Canparison of pressures (rrmHg) in the pulmonary and 
systemic circulations - from J.B. West (1979). Res-
piratory Physiology. Williams and Wilkins Canpany; 33 
35 
The distribution of blood in the pulmonary capillaries is affected by 
gravity (change in posture) and active physiological responses causing 
the capillaries to constrict (i.e. reduction of alveolar P02, low blood 
pH). It is however a highly non-linear response. 
Starlings Law 
The alveoli containing the respiratory gas, are separated by thin septa 
(approximately 0,5 urn) from the blood in the capillaries; fluid balance 
between these two units is extremely delicate and in case of pathology 
the alveoli can easily be flooded with fluid (pulmonary oedema). The 
net fluid flow can be described by Starling's equation: 
JV = KF [ ( Pc - Pi) - 6. ( Tfo - TT i) ] -(3.12) 
JV net volume flow [!/min] 
KF filtration coefficient [l/rnin-lil11Rg] 
Pc pulmonary rnicrovascular pressure [rrmHg] 
Pi interstitial pressure [ rnrnHg] 
(} Staverrnan reflection coefficient 
11c Capillary oncotic pressure [ rnrnHg] 
TTi Interstitial oncotic pressure [rnrnHg] 
The earliest form of pulmonary oedema is characterised by accumulation of 
fluid in the interstitial space and is known as interstitial oedema. The 
practical use of Starling's equation is unfortunately limited, because of 
our ignorance of many of the variables. Because Starling's law appears 
so simple, it is common practice to measure a few variables involved, 
substitute "commonly accepted values" for the unmeasured variables, and 
create any physiological state to prove a point. It can however be 
assumed with reasonable certainty that alveolar oedema could at least 
partially be explained by this equation; especially if accompanied wi th a 
change in the Staverrnan reflection coefficient, related to the 
permeability of the alveolar wall. 
Respiratory gases are transported in the blood, which acts as an inter-
mediate medium between the gas exchange apparatus and the tissue. In 
fact the prime function of blood is that of transport, not only the 
36 
respiratory gases, but also various other substances. It follows logi-
cally that blood physiology has evolved in such a way to optimize the 
transport of o2 and cn2• 
3.1.4.2 Oxygen transport: A small percentage of o2 (about 3%) is dis-
solved in the water of the plasma and cells, according to Henry's law; 
t he remainder of the oxygen is carried in loose chemical combination with 
haemoglobin in the red blood cells. When the P02 is high (as in the 
pulmonary capillaries) oxygen binds with the haemoglobin, a drop in :i:o2, 
as experienced in the tissue capillaries, causes the oxygen to be re-
leased from the haemoglobin. 
The relationship between the P02 and amount of oxygen bound to the 
haemoglobin, i.e. the percent saturation of the haemoglobin, is not 
linear. The exact relationship is conveniently described by the oxygen 
haemoglobin dissociation curve, it is sigmoidal, the exact shape of which 
is determined by various blood-chemical factors. A typical oxygen dis-
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Figure 3.5 Shift of the o2 dissociation curve by pH, PCD2 and 
Temp - from J.B. West (1979). Respiratory Physio-
logy. Williams and Wilkins Company; 73. 
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Note that the following blood-chemical factors cause the curve to "shift" 
towards the right. 
a. increased hydrogen ion content (decreased pH). 
b. increased co2 content (Bohr effect). 
c. increased temperature. 
d. increased 2,3 diphosphoglycerate (DPG); a phosphate compound 
normally present in blood. 
Inherent to the shape of the curve and the factors influencing it, are 
various physiological advantages and safeguards. The flat shape in the 
upper region renders the o2 content less sensitive for P02 changes in 
that region, whereas the steep portion implies that the tissue can 
withdraw large amounts of o2 without major changes in capillary F02• 
The blood of a normal person contains approximately 15 grams of haemo-
globin in each 100ml of blood, and each gram of haemoglobin can bind with 
a maximum of approximately 1, 34ml of oxygen when 100% saturated. It 
follows that 100ml of fully saturated blood contains approximately 20ml 
of oxygen. 
3.1.4.3 Carbon Dioxide Transport: Transport of carbon dioxide in the 
blood is not as critical as transport of oxygen; it can be transported in 
far greater quantities than in the case of oxygen. Carbon dioxide has, 
however, a profound influence on the acid-base balance of the body fluids 
and its control is therefore just as critical. 
An average of 10% co2 is transported in the dissolved state, the remain-
der is carried as plasma bi carbonate (70%) in combination with plasma 
proteins bound to haemoglobin (20%). 
The carbon dioxide dissociation curve (Fig. 3.6) depicts the dependence 
of the total blood co2 content (in all the forms) on the PC02. The lower 
the saturation of Hb with o2, the larger the CO2 content for a given 
PC02; this phenomenon is referred to as the Haldane effe
ct. 
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Figure 3.6 CD2 dissociation curves for blood of different o2 
saturations. Note that oxygenated blood carries 
less CD2 for the same PCD2• The "physiological" 
curve between arterial and mixed venous blood is 
also shown - from J.B. "West (1979). Respiratory 
Physiology. Williams and Wilkins Company; 77 
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3.1.5 Acid-Base Status: The hydrogen ion concentration [H+] of arterial 
blood is normally kept very close to 38,9 nM/1 corresponding to a pH of 
7,41. This normal value is protected by a combination of passive (chemi-
cal) and active (physiological) buffering reactions. The respiratory 
system and kidneys are most important in the case of physiological buf-
fering. The lungs excrete a hundred times as much acid per day compared 
to the kidneys; it follows that the lungs play a major role in the 
control of the acid-base balance of the body fluids. 
The Henderson-Hasselbach equation defines the relative bicarbonate (HCD3) 
and CD2 ratios to produce a given blood pH: 
pH = 6,1 + log [HCDj] -(3.13) 
0,03.PCD2 
[HCD3] concentration in nM/1 or mEq/1 
Pa)2 mmHg 
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The bicarbonate concentration is determined chiefly by the kidneys and 
the PC02 by the lung; as long as t
he ratio [HC03]/(PCo2·0,03) remains 
equal to 20:1 the pH will remain at 7,4. 
This ratio can be disturbed either by an increase or decrease in [HC03] 
or by an increase or decrease in blood PC02 ; each one of these 
disturbances gives rise to a characteristic acid-base balance. 
The Davenport diagram (Fig. 3.7) depicts the relationship between [HC03] 
pH and PC02 and possible deviations from the
 norm. 
A. 













< 10 ....J 
a.. 



















7 l 7.4 7.7 pH 
pH UNITS ACIDOSIS ALKALOSIS 
Figure 3.7 Davenport diagram showing the relationships between 
HC03, pH and PC02. A shows the buffer line BAC. B 
shows the changes occurring in respiratory and 
metabolic acidosis and alkalosis - from J.B. West 
(1979). Respiratory Physiology. Williams and 
Wilkins Company; 81. 
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a. Respiratory acidosis: Caused by an increase in PC02 and conse-
b. 
c. 
quently a decrease in pH. (Can be caused by hypoventilation or 
ventilation-perfusion inequality.) 
If this condition persists, the kidneys will respond by conserving 
HCD3 and the condition is then referred to as compensated respira-
tory acidosis. The extent of the renal compensation can be deter-
mined from the standard bicarbonate value (plasma bicarbonate when 
the blood is equilibrated at the normal POJ2 of 40 mmHg). 
Another way of expressing the compensation is by calculating the 
base excess (BE); i.e. the amount that the plasma [HC03], measured 
at a pH of 7,4 exceeds that of the normal value (24 mEq/1). 
Respiratory Alkalosis: It is caused by a decrease in PC02 and an 
elevation of the pH (may be a result of hyperventilation). Renal 
compensation occurs as an increased excretion of HC03, resulting in 
a negative base excess or base deficit. 
Metabolic Acidosis: A decrease in the HC03 concentration (due to a 
primary cause) followed by a decrease in the pH (loss of sodium 
bicarbonate through diarrhoea could be a cause). 
Respiratory compensation occurs as an increase in ventilation which 
lowers the POJ2. A base deficit is measured. 
d. Metabolic Alkalosis: An increase in [HCD3] due to a primary cause, 
followed by an increase in the pH. · Loss of acid gastric juice 
(excessive vomiting) may give rise to this condition. 
Respiratory compensation may occur by a reduction in alveolar 
ventilation, raising the POJ2. A base excess is measured. 
Respiratory gas transport is summarized in Fig. 3.8. 
PEo, = 115 mm Hg 
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Figure 3.8 Diagrammatic representation of the respiratory gas trans-
port system - from F.S. Grodins and S.M. Yamashiro (1978). 
Respiratory function of the lung and its control. 
Macmillan Publishing Co.; 5. 
3.2 A SYSTEMS APPROACH 
3.2.1 Introduction: Historically, physiology originated primarily from ana-
tomy and histology, which resulted in a sub-division of physiology into 
various so-called physiological "systems"; i.e. respiratory, circulatory, 
nervous, endocrine. These "systems" are, however, closely related to the 
individual functional anatomical com.!X)nents, with the emphasis placed on 
analysis of the function and interaction of these individual components, 
i.e. lungs, heart, brain, glands, etc. 
In recent years a new approach has emerged, with the emphasis placed on 
analysis of the so-called individual unit process followed by a synthesis 
of the complete system. The overall behaviour of a complex system is 
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studied in terms of interacting unit processes as well as interaction 
with other systems. The unit process is chosen to contribute to useful 
understanding and may not be directly related to the anatomy of the unit 
(Grodins, 1978 ). 
It is believed that the functioning of the complete system, as 
synthesized from the individual unit processes, is far more complex than 
the sum total of the indi victual unit processes. In order to study the 
dynamic response of the system and its detailed functioning, a 
qualitative approach proved to be unsatisfactory; instead the response 
should be studied in terms of a well-developed scientific method. 
Engineering control system theory and related mathematical principles 
lend themselves to such an application. It is in this field that the 
engineer with a thorough understanding of related biology, referred to as 
a bio-engineer (sub-division of biomedical engineering), can contribute 
towards a better understanding of biological systems. 
The terms 'systems analysis' and more specifically 'systems physiology', 
are recognised as referring to this new approach; they should not, how-
ever, be confused with the physiological "systems" referred to in the 
introductory paragraph. 
3. 2. 2 Biological Processes: The rnajori ty of organisms, depending on their 
level of sophistication can be sub-divided into the following major 
processes (Jaros, 1982a): 
a. Cellular Processes: The cell is the building block of any living 
organism, in fact it could be regarded as the primarily requirement 
to sustain life as we know it. It represents a unit process, al-
though we rather tend to analyse a specialised collection of cells, 
structured to perform a specific function. The majority of the 
chemical processes, forming the basis of life, are initiated and 
completed within the cell. 
b. Homeostatic Processes: For the cell to survive, it requires a very 
specialised internal environment (milieu interne), maintained at 
c. 
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relatively constant values. The various ion concentrations and 
osmolality of extracellular fluid are typical requirements to ensure 
the continuation of the living cell. Homeostasis means the main-
tenance of constant conditions in the internal environment; i.e. the 
region in direct contact with the living cell. Various organs and 
tissues contribute towards the homeostatic processes, playing a 
major part in the maintenance of favourite conditions for the cells 
and consequently life. 
Defence Processes: The organism under discussion must act against 
the intrusion of hostile organisms and therefore needs a defence 
system. Whereas the homeostatic processes ensure the maintenance of 
a favourite internal milieu, the defence processes ensure the con-
tinuation of the living organism in a hostile external environment. 
The defence processes, if functioning correctly, act on behalf of 
the complete organism and ensure survival in the long term; e.g. the 
immune processes. 
d. Reproductive Processes: Once survival of the organism itself has 
been secured in the existing environment, it is essential that the 
organism replaces obsolete cells and finally reproduces itself, in 
order to ensure its future existence as well as that of the species. 
It involves continuous reproduction on a cellular level and, in case 
of multi-cellular organisms, that of the whole organism. 
e. Orientation Processes: In order to survive and perform the func-
tions related to the previously mentioned processes, it is often 
necessary for the organism to orientate itself in response to either 
internal or external stimuli. The organs involved in higher or-
ganisms are mainly the various receptors, musculo-skeletal system 
and nervous system. 
The sub-division of the various life processes is merely an 
artificial exercise and it must be emphasized that all the processes 
are interrelated; it is often rather the interaction between the 
various processes that is under investigation in systems physiology. 
A diagrammatic representation of the various processes is presented 
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Homeostatic processes are of particular importance in so far as this 
thesis is concerned, especially the process responsible for the 
control of PCD2, ID2 and pH in the extracellula
r fluid. It is with 
this in mind that the homeostatic process will now be analysed in 
more detail. 
3.2.3 Homeostasis: A homeostatic process always involves the control of a 
specific entity and as such it presents itself for the application of 
engineering control system theory. Homeostatic processes can be further 
sub-divided into a collection of sub-systems (Jaros, 1982b). 
a. Terminal System: The terminal system forms the basis of con tact 
with the external environment of the organism and is involved in the 
exchange of information and solid substances. Examples are the 
lungs, alimentary canal and the kidneys. 
b. 
c. 
Intermediate System: This system acts as a store for the substances 
being controlled and, in some instances, alteration or filtering of 
the substances occur within the intermediate system. Examples are 
the liver, bone, adipose tissue and the reticule-endothelial system. 
Control System: Homeostasis requires the maintenance of various 
parameters within very small tolerances under extreme conditions. 
It follows logically that a control system is required, in order to 
co-ordinate and monitor the activity of the other sub-systems. 
Control in biological systems al ways relies on negative feedback 
mechanisms to maintain the variables within the acceptable limits; 
an irreversible state of shock would be an example of a condition 
where positive feedback exists in the control loop. Control is 
usually a combination of the following processes: 
i. Autoregulation: I.Deal control of the variable; for instance, vaso-
constriction in the case of pulmonary capillaries. 
ii. Endocrine control: Hormonal control of the variables; the hormones 
are excreted by the various glands in response to hormonal and 
nervous stimuli and are then distributed in the blood to their 
target organ(s). 
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iii. Autonomic nervous control: The autonomic nervous system controls 
the activity of various organs and glands (e.g. lungs, circulation, 
digestive system and interaction with endocrine system) via the 
nerve tracts. 
d. Transport System: The transport system ensures the distribution of 
the entity being controlled, from the terminal systems, via the 
intermediate system, to the cells and ·vice versa. Distribution 
could be either via the blood, lymph or nerve tracts. It is impor-
tant to note that the transport system also acts as a communication 
link (conveying of information) and not only the distribution of 
substances. A diagrammatic representation of the homeostatic sub-
systems is displayed in Fig. 3.10. 
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Figure 3.10 Diagranrnatic representation of the 
haneostatic sub-systems. 
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On completion of this rather lengthy introduction to systems physio-
logy, the respiratory system should be referred to as (pH, P02, 
P(l)2] homeostasis. For convenience the process will be r
eferred to 
as respiration homeostasis in subsequent discussions. 
3.2.4 Respiration Haneostasis 
3.2.4.1 Terminal System: The function of the terminal system in respi-
ration homeostasis is fulfilled by the lungs and kidneys. As mentioned 
in the previous paragraph, three variables are being controlled, namely 
the pH, P02 and P0)2. The kidneys fulfil a direct function in the 
regulation of pH, although the lungs dominate also in that respect (the 
pH and P(l)2 are closely related as demonstrated in equation 3.13. 
The concept of a continuous ventilation-perfusion ratio distribution in 
the lungs is of vital importance in the successful understanding of gas 
exchange in this region. 
Intuitively it should be clear that there exists an optimum ratio of the 
air flow in a specific alveolus to the blood flow in the capillaries 
supplying it. A redundancy or shortage in either one of these entities 
will cause a "mismatch" between the gas and blood phase, causing insuffi-
cient or non-optimal gas transfer for that specific unit. The ventila-
tion-perfusion ratio distribution is discussed in greater detail in a 
subsequent chapter. 
3.2.4.2 Transport System: The systemic and pulmonary circulation play a 
major role in respiration homeostasis and any defect in its operation may 
have a profound influence on the variables being controlled. 
The respiratory gases either dissolve in, or combine with, the blood and 
its chemical constituents; of relevance are the oxygen and carbon dioxide 
dissociation curves and how it may influence the concentration of the 
respective gases. 
3.2.4.3 Intermediate System: There is no significant intermediate sys-
tem present for any one of the controlled variables; i.e. respiratory 
gases are not stored in significant quantities over an extended period 
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(blood may be considered to act as an intermediate system, although the 
volume of gases stored is sufficient only for a very short period). This 
has important physiological consequences; the best that could be done in 
case of a lack of oxygen for instance, would be for the oxygen rich blCX>d 
to be diverted to the most critical regions; i.e. the brain and heart. 
3.2.4.4 Control System: Control of respiration homeostasis should be 
analysed in terms of its influence on the various sub-systems; i.e. 
terminal and transport. It involves control of circulation, ventilation 
and renal function. The ideal would be to combine the various units into 
a ma them a ti cal model, depicting all the unit processes, feedback mec-
hanisms and interrelating pathways; output variables would be pH, PCD2 
and P02 in the blood. 
This is a formidable task and progress has been made in the fields of 
circulation, respiration (Dickinson, 1979) and renal function (acid-base 
balance) individually; a holistic model of respiration homeostasis has 
not been sucessfully completed to date. 
Fig. 3.11 is analogous to Fig. 3.10 but has been adapted to respiration 
homeostasis. It is believed that the kidney plays a minor role in the 
regulation of pH, compared to the lungs; its function is probably more 
relevant in the control of blood pressure and fluid balance. 
A diagram of the "metabolic servomechanism" as designed by Grodins et al. 
(1978) is presented in Fig. 3.12. This diagram conforms in pattern and 
purpose to a simplified approach towards respiration homeostasis. In 
constructing it, they have assumed that the respiratory system comprises 
a metabolic servomechanism designed to match pulmonary and metabolic gas 
exchange ratios over a wide range with little change in arterial composi-
tion. 
. 
They have further assumed that VA (alveolar ventilation) varies in direct 
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Figure 3.12 Block diagram of the modified respiratory chemostat (i.e. 
the metabolic servomechanism) including a dual role of 
VCD2 (information flow to controller, material flow to 
gas exchanger) - from F.S. Grodins and S.M. Yamashiro 
(1978). Respiratory function of the lung and its control. 





AOOLT RFSPIRA'IDRY DISTBBSS SYNLU:IIE (AROO) 
4.1 INTRODUCTION 
The adult respiratory distress syndrome (ARDS), so called because of 
similarities with the infantile respiratory distress syndrome, was first 
described as a clinical syndrome in 1967 by Ashbough et al. Advanced 
evacuation and resuscitation techniques of military patients during the 
Vietnam war allowed patients to be observed over extended periods in 
hospital, highlighting the occurrence of ARDS in patients suffering from 
severe trauma (Petty, 1982). 
The syndrome is characterized by hypoxaemia, bilateral pulmonary infil-
trates, severe dyspnoea and a reduction in lung compliance. It is pre-
ceded by a variety of catastrophic insults or risk factors (Petty & 
Fowler, 1982). The clinical signs become evident only after a period of 
approximately 12 to 48 hours following the initial insult; a positive 
diagnosis is very difficult to make before the onset of severe hypoxae-
mia. The mortality rate may be as high as 80% and usually varies from 
30% to 80% in the case of patients diagnosed according to the severity 
criteria laid down by Petty & Fowler (1982). 
The exact mechanism of ARDS is, to a large extent, unknown. Based on a 
systems approach (vide infra) it can however be stated that the secondary 
cause is to be found in the terminal system, especially the lungs, where 
impairment of gas exchange occurs as a direct result of ventilation -
perfusion inequalities (King et al., 1974; Ralph & Robertson, 1981; 
Dantzker, 1982). 
The primary cause is believed to be biochemical in nature and is believed 
to act upon the terminal system via the circulatory system (Dauberschmidt 
et al., 1982; Lamy et al., 1983; Petty & Fowler, 1982). Surfactant 
function seems to be of profound importance and depletion might 
eventually prove to be a primary mechanism of the syndrome (Bone, 1976b; 
Petty et al., 1977; Petty et al., 1979; Massaro et al., 1980). 
Changes in the haemodynamic status should be viewed as a result of de-
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fects in the terminal system and are not to be confused with the primary 
causes (Ayres, 1982; Jardin et al., 1979a; Shoemaker et al., 1980; Czer 
et al., 1980; Laver et al., 1979; Sibbald et al., 1983). 
Early prophylactic treatment and close monitoring is essential to reduce 
the risk of patients who are potential candidates for ARDS and increases 
the chances of survival in ARDS patients; intelligent interpretation of 
the various physiological variables should ideally be integrated towards 
a goal directed therapy (Boysen, 1982; Bland et al., 1978; Czer et al., 
1980; Gong, 1982; Schoemaker et al., 1980). 
4.2 DIAGNOSIS 
There is no single "marker" of the syndrome which can be incorporated 
into a single diagnostic test for the diagnosis of ARDS; instead one must 
rely on a description of the clinical syndrome as a definition. 
Criteria for diagnosing ARDS have been described by Petty & Fowler (1982) 
and serve as a quantifiable diagnostic technique. 
4.2 . 1 Criteria for diagnosis (Petty & Fowler, 1982): 
a. Clinical history of catastrophic event: 
(i) Pulmonary (e.g. aspiration, massive infection, contusion) 
(ii) Non-pulmonary (e.g. shock, multisystem trauma) 
exclude : 
chronic pulmonary disease 
left ventricular failure (wedge pressure> 12 cm H20) 
b. Must have clinical respiratory distress 
(i) tachypnoea > 20 breaths/minute 
(ii) laboured breathing 
c. With chest radiograph showing : 
(i) diffuse pulmonary infiltrates (early interstitial, followed 
by alveolar) 
d. And physiological measurements of 
(i) Pao2 < 50 mm Hg when FI02 > 0,6 
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(ii) total dynamic respiratory compliance< 50 ml/cm H2o (usually 
20 to 30) 
(iii) increased shunt fraction and deadspace ventilation 







(i) Direct pulmonary contusion 










d. Disseminated intravascular coagulation 
e . Fat emboli 
f. Amniotic fluid emboli 
g. Aspiration: especially of highly acidic gastric contents (pH< 2,5) 
h . Near drowning 
i. Inhaled toxic agents 
(i) Smoke 
(ii) Phosgene 
(iii) oxides of nitrogen 
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j. Pancreatitis 
k. Oxygen toxicity 









4.3.1 Pulmonary Oedema: While the underlying pathology associated with ARDS 
is myriad and not clearly understood in all cases, acute abnormalities of 
pulmonary function result from the progressive accumulation of extravas-
cular fluid (Dantzker, 1982). Hypoxaemia of ARDS is primarily due to 
pulmonary oedema which results in a right to left shunt; the concept of a 
physiological shunt is however often confused and should actually be 
regarded as the integration of the effect of ventilation - perfusion 
inequalities in the lung (West, 1977; King et al., 1974), combined with 
the anatomical shunt. 
Two forms of pulmonary oedema have been described: haemodynamic or 
cardiogenic oedema, in which fluid accumulates secondary to changes in 
hydrostatic and oncotic pressures and permeability oedema, which is 
characterised by functional or anatomical damage of the pulmonary 
microvascular membrane (Wiener et al., 1983). It appears, however, that 
a protein-permeable epithelium alone does not induce alveolar oedema, but 
usually a combination of both effects (Egan, 1982), al though the 
mechanisms differ (Staub et al., 1967). 
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Dantzker (1982) concluded from experimental data that blood flow in ARDS 
is distributed mainly to two types of lung units; those normally 
ventilated and those unventilated. This all-or-none phenomenon is 
consistent with a theory that alveolar flooding is either complete or 
absent. 
The mechanism of pulmonary oedema could be described by employing 
Starling's equation (Staub, 1974); it has, however, given rise to contro-
versy and is by no means a clear cut-approach (Civetta, 1979). 
The sequence of pulmonary oedema can be sub-divided into a few distinct 
phases (Staub et al., 1967): Fluid appears first in the interstitial 
connective tissue around the large vessels and airways, followed by 
alveolar wall thickening, and finally rapid and independent alveolar 
filling after the interstitial compartment is well filled. Increased 
surface tension favours fluid leakage, presumably because it increases 
the microvascular transmural pressure (Albert et al., 1979). 
4.3.2 Surfactant Abnormalities: Abnormalities in pulmonary mechanics are 
characterised by reduced lung compliance, and morphologically the lungs 
are congested and atelectatic. 
Surface compressibility, or its reciprocal which is surface elastance, is 
an expression of the resistance of the surface film to compression at any 
given area. In a study conducted by Petty et al. (1979), the films from 
ARDS lungs had a high value of compressibility which demonstrates that 
these films are unable to adjust rapidly to stress, in contrast to the 
nonnal films with low values of compressibility. 
Surfactant abnormalities are believed to be a result and not a primary 
cause of ARDS, which begins as a result of a catastrophic insult (Petty 
et al., 1977). It does, however, remain a reasonable hypothesis that 
surfactant abnormalities in ARDS play a secondary but vital role in the 
pathogenenis of the clinical syndrome through the mechanism of encourage-
ment of further intra-alveolar fluid sequestration, further alteration in 
lung mechanics, and reduced functional residual capacity resulting in a 
vicious circle leading to shunting and refractory hypoxia (Petty et al., 
1979). 
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It has been hypothesized (Massaro et al., 1980) that shallow breathing 
leads to the aggregation of surfactant into a less functional form 
resulting in increased alveolar surface tension and atelectasis. 
Whatever the situation may be, it appears as if a definite correlation 
exists between changes in lung compliance and the onset of ARDS (Bone, 
1976a;Bone, 1976b; Petty et al., 1979). 
4.3.3 Haemodynamic Disorders: As a result of defects in the respiratory 
terminal system in ARDS patients, combined with the effects of the ini-
tial insult, the function of the circulation is altered primarily by the 
control system as a compensatory measure. Therapy, for instance ventila-
tory support, may also influence its functioning. 
The patient with post-traumatic ARDS has circulatory and metabolic 
demands which are greater than normal values defined from healthy 
unstressed volunteers and also somewhat greater than haemorrhage and 
trauma patients without ARDS (Czer et al., 1980). A universal finding in 
all groups of ARDS patients is pulmonary hypertension and also a 
progressive increase in the mean pulmonary arterial pressure (MPAP) in 
patients who eventually died (Jardin et al., 1979; Czer et al., 1980). 
Pulmonary hypertension has two important haemodynamic consequences 
a. It causes an elevated afterload for the right ventricle with an 
excessive right ventricular stroke - work index (Jardin et al., 
1979) which can produce right heart failure (Sibbald et al., 1983). 
However, straightforward application of the Frank - Starling 
principle to an analysis of right ventricular and left ventricular 
function after an extensive acute destruction of pulmonary 
vasculature architecture may be inappropriate (Laver et al., 1979). 
b. It is probably in part responsible for an abnormally low systemic 
arterial pressure due to reduction in systemic arterial resistance 
(Jardin et al., 1979). 
Whatever the interpretation may be, management of systemic haemodynamic 
disturbances complicating the early state of ARDS, such disorders as a 
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hyperkinetic state, myocardial failure, hypovolemia or overperfusion can 
enhance hypoxaemia and myocardial failure or hypovolemia may be worsened 
by the use of mechanical ventilation with positive end expiratory 
pressure (PEEP) (Ellman et al., 1982; Jardin et al., 1981; Cassidy et 
al., 1981; Pick et al., 1982; Perschau et al., 1979). 
A block diagram of the pathophysiology is given in Fig. 4.1. 
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Figure 4.1 Pathophysiology of ARDS - data fran T.L. Petty (1982). 
Another look at ARDS. Chest, 82; 99. 
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4.4 VENTILATION/PERFUSION RELATIONSHIPS AND GAS EXCHANGE IN THE LUNGS 
Gas exchange in the lungs occurs at the level of the alveoli; to be more 
exact, at the interface between the air and the blood phases of 
ventilation and perfusion respectively. A few concepts as regards the 
gas and blood phases are noteworthy and should be thoroughly understood 
before an attempt can be made to analyse optimum gas exchange in the 
lungs. 
The inspired air is distributed amongst the individual alveoli; after 
diffusion has occurred and a state of equilibrium has been reached within 
each one of the alveoli, the individual expired alveolar a ir 
concentrations are summed in the airways, finally to produce the expired 
air concentration measured at the mouth. 
Individual alveolar air concentrations vary and do not necessarily 
resemble the (mixed) inspired or mixed expired air concentrations at the 
mouth. 
By analogy, the mixed venous blood of the blood phase corresponds to the 
inspired air and the pulmonary capillary blood gas content to the 
alveolar air concentrations. 
An optimum ratio of the alveolar gas and pulmonary capillary blood flow 
exists; i.e. air flow re pre sen ts a specific oxygen supply and the blood 
flowing in the capillary has a limited capacity to absorb a specific 
volume of oxygen - for optimum gas transfer these two gas delivery and 
carrying capacities should be equal. The ratio of the alveolar air flow 
(ventilation) and capillary blood flow (perfusion) at this point, is the 
optimum ventilation-perfusion ratio for that specific alveolus. 
It must be emphasized that it is the ratio of the ventilation to 
perfusion in an individual alveolus that determines the effectiveness of 
the gas transfer in that alveolus and not the absolute value of any one 
of the two entities. The air and blood flowing to two separate alveoli 
may differ drastically but both will operate at the optimum point, as 
long as the ratios are equal and optimal. 
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The "ideal" alveolar and arterial gas concentration points are obtained 
when the mixed alveolar air concentrations and mixed pulmonary capillary 
(arterial) gas concentrations are derived at the average ventilation-
perfusion ratio for a specific lung, which does not necessarily equal the 
optimal ratio. 
Since a situation where all alveoli function at the ideal point does not 
exist in real life, the concept of a statistical distribution of VA/Q 
fractions in the alveoli was introduced (Riley & Courand, 1948; West, 
1977; Evans et al., 1974). 
Due to the fact that all the alveoli do not function at the ideal point, 
gas is not exchanged up to a point where the oxygen content is depleted, 
although a state of equilibrium does exist. This gives rise partially to 
the alveolar-arterial oxygen tension difference [P(A-a)02 ] and is a 
direct result of a combination of three independent phenomena: diffusion 
impairment, venous admixture (anatomical) and unequal ventilation-per-
fusion ratios among the alveoli, including true shunt (Farhi & Rahn, 
1955). A state of diffusion impairment could be present in, for ins-
tance, some patients suffering from chronic pulmonary disease. 
A different approach towards the study of blocxi gas exchange in the lung 
was followed by King & Briscoe, 1967; namely the construction of Bohr 
integral isopleths and ventilation - perfusion ratio isopleths 
superimposed on the oxygen dissociation curve. 
4.4.1 Presentation and measurement of ventilation/perfusion ratio (V~/Q): A ...... 
major description problem exists in the presentation of the VA/~ 
distribution; the problem is how to properly handle multiple gas data so 
as to gain the greatest amount of insight into the properties of VA/Q 
distributions, without overstepping the theoretical limitations inherent 
in the particular techniques and without throwing away useful information 
(Wagner, 1976; Evans & Wagner, 1977; Wagner, 1981). The data are 
normally displayed with the VA/Q on the abscissa and the ventilation and 
perfusion values respectively on the ordinate. 
Continuous VA/Q distributions have been measured in patients by combining 
·the nitrogen washout technique with varying values of F1o2 (Briscoe et 
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al., 1960; Okubo & Lenfant, 1968; Lenfant and Okubo, 1968). A typical 
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Figure 4.2 Examples of ventilation/perfusion distributions in 
normal subjects. The left panel shows the result 
in a young subject and the right panel the results 
in an older man - from J.B. West (editor) (1977). 




The VA/Q distribution in subjects suffering from ARDS tends to be 
bimodal, with regions of very low VA/Q participating in the overall gas 
exchange; no single unique pattern has however emerged from measurements 
performed in these subjects (Wagner et al., 1974; Dantzker et al., 1979). 
The concomitant change in the V A/Q distribution presents itself as an 
attractive method of early diagnosis and prediction of the onset of ARDS 
in traumatic patients. The nucleus of this thesis is, in fact, based on 
this hypothesis and will be elucidated in the subsequent chapter. An 
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Figure 4.3 Venilation/Perfusion distribution in a patient 
with the adult respiratory distress syndrome -
fran R.D. Dantkzker (1979). Am. Rev. Resp. 
Dis . , 120; 1039. 
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4.4.2 Gas transfer in ARDS patients: A decrease in blood oxygen content and 
unresponsiveness to oxygen administration characterise the diagnostic 
syndrome of ARDS (Petty, 1982; Petty & Fowler, 1982). 
Carbon dioxide retention has also been observed in ARDS patients (Ralph & 
Robertson, 1981); very few studies are clear about this aspect and 
usually expired CD2 is not measured. 
The possible determinants of altered gas exchange in the lung are 
believed to be threefold: 
a. A "true shunting" of blood; blood passing totally unventilated 
alveoli. . . 
b. The perfusion of regions with very low VA/Q. 
c. A diffusion impainnent in the functional alveoli. 
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In ARDS patients, it appears as if a "true shunt" is the predominant 
mechanism of hypoxaemia, accompanied by regions with very low VA/Q (Ralph 
& Robertson, 1981; Dantzker et al., 1979). It has been estimated with a 
mathematical model of the gas exchange process that diffusion impairment 
does not contribute significantly towards hypoxia (Dantzker et al., 
1979); it cannot be ruled out with any certainty, however (Ralph & 
Robertson, 1981). 
Although the gas exchange abnormalities (King et al., 1974; Danek et al., 
1980; Dantzker, 1982; Ralph & Robertson, 1981), pulmonary mechanics 
(Petty et al., 1979; Petty et al., 1977; Bone, 1976a,b) and pathologic 
findings (Ayeres, 1982; Lamy et al., 1976) in ARDS have been well 
described, correlations between these measurements and the evaluation of 
histologic alterations in the injured lung remain mostly a matter of 
speculation. The only study that extensively correlated observed 
pathologic changes with measurements of gas exchange and prognosis in 
humans with ARDS is that of Lamy et al. (1976). 
The following facts concerning gas exchange in ARDS patients may, 
however, be assumed with reasonable certainty (Dantzker, 1982): 
a. The acute abnormalities of pulmonary function, in all cases, result 
from the progressive accumulation of extravascular fluid in the 
lung. 
b. The progression of events is similar irrespective of the aetiology 
of the oedema; viz. increased hydrostatic pressure or increased 
capillary permeability. 
c. Flooded alveoli are widely scattered throughout the lung, with 
filled alveoli often adjacent to uninvolved ones. 
d. Hypoxaemia of ARDS is primarily due to pulmonary oedema which 
results in right to left "true shunt". 
e. In addition, hypoxaemia may be caused by the presence of regions 
with low (0,02 - 0,1) VA/Q's as well as the possibility of diffusion 
impairment, although is unlikely to be so. 
The regions with low VA/Q's are especially noteworthy, since it actually 
implies a bimodal VA/Q distribution in the lungs with a concomitant 
increase in the physiological shunt. 
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4.5 PATIENT MANAGEMENT 
4.5.1 Introduction: Skillful management of fluids is essential in 
maintaining an adequate circulation and avoiding further complications 
(Petty & Fowler, 1982; Bone, 1978; Gallagher et al., 1978; Venus et al., 
1979; Walkinshaw & Schoemaker, 1980). Whereas aggressive fluid therapy 
was the rule in management of shock before the characterization of ARDS, 
it subsequently became clear that fluid overload is an important 
complicating factor in ARDS (Wood & Prewitt, 1981; Jardin et al., 1979). 
The use of corticosteroids in the treatment of ARDS patients is wide-
spread but controversial (Petty & Fowler, 1982). If given early, they 
can reduce lung injury and maintain alveolar stability and prevent damage 
of the capillary epithelium. Unfortunately, they may also reduce lung 
macrophage antibacterial defences. 
FI02 should always be kept as low as possible (preferably less than 0,5) 
in order to reduce the risk of atelectasis and oxygen toxicity (Dantzker 
et al., 1974; Ayeres, 1982). In severe cases of ARDS it may however be 
necessary to maintain levels of 100% oxygen supply over extended pericxis 
in order to ensure an acceptable level of Pao2 (Lamy et al., 1976). 
The hypoxaemia accompanying ARDS is significantly improved with sustained 
application of a modified form of spontaneous or mechanical ventilation, 
combined with positive end-expiratory pressure (PEEP). To date, PEEP in 
its various forms represents the most effective, but not ideal (vide 
2.4.2.1), means of treatment. 
4.5.2 Ventilatory Support: Intermittent mandatory ventilation (IMV) with 
PEEP offers a few advantages over a rigidly controlled mode of ventila-
tion. IMV reduces the mean intra-thoracic pressure and therefore reduces 
the risk of barotrauma and other mechanical deleterious effects, 
especially if used in conjunction with PEEP (Gong, 1982; Bone, 1978). 
Tidal volume and respiratory rate are determined by the state of the 
patient (tidal volume is usually set between 10 and 12 ml per kilogram of 
body weight) (Petty & Fowler, 1982). Fig. 4.4 depicts a typical pressure 
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Figure 4.4 Intermittent mandatory venilation with PEEP 
It is possible to determine the ideal ventilatory pattern with a 
simulation of lung mechanics and optimal ventilation parameters (Barbini, 
1982). In practice an ideal ventilator neither exists nor can it be 
designed (due to conflicting physiological interests); it could, however, 
be utilized in such a way as to optimize the parameters which, in each 
case, are considered the most important. 
High frequency ventilation (HFV) offers another possibility for 
ventilatory support, it seems as if it might be superior to other 
ventilatory techniques. Controlled studies of HFV in ARDS are still 
required before any real answers will be forthcoming (Gallagher et al., 
1982). 
A controversy exists over the exact amount of PEEP that should be applied 
to optimize gas transfer to the tissue. A reduction of cardiac output 
tends to occur proportional to increments of PEEP and is generally most 
marked with PEEP > 10 cm H20. The magnitude of the effect varies from 
individual to individual and results from a complex balance among 
several factors; the most important of which are: the status of the 
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cardiovascular system, lung compliance and the functional residual 
capacity (FRC) (Jardin et al., 1981; Cassidy et al., 1981; Pick et al., 
1982; Ellman and Dembin, 1982; Perschau et al., 1979; Simonneau et al., 
1982). 
An "optimal" combination exists between the level of PEEP administered 
and the cardiovascular status; the exact combination and parameters that 
should be optimized are, however, still controversial (Suter et al., 
1975; Civetta et al., 1975; Demers et al., 1977; Gallagher et al., 1978; 
Venus et al., 1979). 
The various physiological parameters involved in oxygen delivery to the 
tissue, with their interaction, are shown in Fig. 4.5. Therapy should be . 
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Figure 4.5 Schematic representation of the therapeutic 
goals in ARDS patients 
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4.5.3 Monitoring: Monitoring of the patient with ARDS is essential and 
should be guided by a strict protocol in order to encourage goal-directed 
therapy. Measurements should, however, always be accompanied by 
intelligent observations performed by experienced personnel. The basic 
methods of physical diagnosis and radiologic examination techniques are 
of prime importance and should not be replaced by advanced monitoring 
techniques; they should rather supplement the fundamental techniques. 
For a detailed discussion of monitoring techniques the reader is referred 
to: (Bone, 1981; Fallat, 1982, Boysen, 1982). 
Blood gases probably represent the most imJX)rtant physiological vari-
ables in patients suffering from ARDS; they give, in conjuntion with the 
cardiac output, a direct indication of the oxygen supply to the tissue. 
Ideally the arterial as well as the mixed venous blood gas content should 
be monitored. Various methods of presenting the data have been suggested 
(Covelli et al., 1983; Bone, 1981; Giovannini, 1983); the most popular 
configurations are the physiological shunt (Qsp/Qt), arterial oxygen 
partial pressure and fraction of inspired oxygen ratio (Pa02/FI02), the 
alveolar-arterial oxygen tension difference [P(A-a)02 ] and the mixed 
venous oxygen tension Pv02. 
Blood gases should always be judged in conjunction with haemodynamic and 
ventilatory variables and a diagnostic or therapeutic decision should not 
be made on the basis of the blood gas content alone. 
The cardiac output, combined with systemic and pulmonary vascular 
pressures constitute the quintessence of haemodynamic monitoring. 
Vascular resistance calculations and haemodynamically derived parameters 
related to cardiac function have evolved over the years, assisting in 
therapy directed towards haemodynamic stability (Boysen, 1982; Schoemaker 
et al., 1979a; Bland et al., 1978). 
Interpretation of the data and directing therapy present a major diffi-
culty. In the past, correlation of derived indices with the underlying 
pa tho logy has been attempted (Schoemaker et al., 1979a, 1979b; 1979c); 
methods relying on observing a trend or analysing a series of measure-
ments appear to be the most reliable. 
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Integration of the most important physiological variables into a quanti-
tative (mathematical) model is one way of overcoming the problem of 
interpretation of multivariable physiological measurements. The fol-




Modelling is the process of building and listing a ma the ma ti cal 
description of a system in close co-ordination with complementary 
experimental studies. 
Two basic approaches to the modelling of physiological systems can be 
distinguished; models with unit processes directly related to the 
physiology of the system that is being modelled and those models that 
follow a "black box" approach, attempting only to model the relation 
between the input and output variables of the system, i.e. the "transfer 
function". In practice, mathematical models of physiological systems are 
a combination of these two approaches. 
It can be stated with certainty that formal mathematical modelling, 
including forcing techniques and analytical techniques adopted from 
engineering, is by now firmly established in physiology and will 
contribute to. a large extent towards future progress in the field of 
biological sciences (Petersen, 1981). 
Identification of redundant comp:)nents in a complex biological system or 
of unwanted information in a mathematical problem is one of the major 
problems confronting the modeller. In the words of Richard Bellman on 
the limitations of mathematics: "We require methods for extracting the 
essential information from the sea of data in which we float. This is an 
extraordinarily clifficu1t problem, or class of problems. We can assert 
that the ability of the human being that is remarkable is not so much the 
ability to handle large amounts of information as the ability to discard 
large amounts and to CXlllcentrate upon the essentials". 
A mathematical model of a biological system may assist in the evaluation 
of the quantitative value of experimental data, to plan the most relevant 
experimental protocol and can contribute towards the identification of 
gaps in our theoretical knowledge of the physiology, which may determine 
the direction of future research projects (Coleman, 1978). 
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The philosphical implications of applying conventional mathematical 
principles to biological systems has been a matter of dispute in the past 
(Brown et al., 1973); the trend seems to be in the direction of 
thermodynamics of general systems (Stear, 1973). 
The vigour of physics as a theoretical as well as an experimental science 
has been manifested in the persistence of metaphysical arguments in 
philosophy that have interacted with work in physics itself to give it 
new direction. Brown et al. (1973) suggested that perhaps biology will 
be mature when a "metabiology" develops and similarly interacts with 
biology which so far is rich in content but p:>or in concept. 
Whatever future developments may take place in the field of modelling, it 
can be asserted that it will make an ever increasing contribution towards 
the advancement of the biological sciences. 
5.2 MATHEMATICAL MODEL OF THE GAS EXCHANGE PROCESS IN THE LUNGS 
Respiration homeostasis involves various interrelating physiological and 
mechanical mechanisms; when attempting to model a system of such 
complexity, it invariably follows that certain aspects will be favoured 
and modelled in more detail, neglecting some of the other mechanisms 
involved. 
The objective of this thesis is to gain more knowledge about the 
pathophysiology involved in ARDS and to apply this knowledge to the 
treatment of these patients. Considering the fact that ventilation -
perfusion inequalities occur in these patients, presumably related to the 
pathophysiology of the syndrome, it was decided that this aspect of 
respiration homeostasis should be emphasized in the mathematical model. 
The VA/Q distribution should be regarded as a sub-section of the terminal 
system of the respiration homeostasis process; this particular sub-
section of respiration homeostasis, therefore, guided the modelling 
process. 
The decision was also influenced, however, by the fact that VA/Q 
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inequalities can be detected by performing measurements on relatively 
accessible physiological variables, i.e. blood flow, gas flow and their 
various concentrations combined with blood physiology measurements. 
The options were either to model one of the other systems in more detail 
(e.g. the transport system, co-ordinating system) or to adopt a 
mechanical approach towards the terminal system, emphasizing the role of, 
for instance, surfactant deficiencies on lung mechanics and consequently 
on gas exchange in the lungs. It is, however, difficult to attach a 
unique quantitative value of, for instance, alveolar elastance to a 
specific set of physiological variables. 
Although the primary cause of ARDS is probably biochemical in nature, it 
is difficult to perform those biochemical measurements involved and also 
to model the processes - it was thus ruled out as a possible basis for 
the model. 
In developing the model, the co-ordinating system has been ignored 
completely with the transport system featuring only in the interface with 
the terminal system, i.e. the gas dissociation curves and cardiac output 
values. It is believed that changes in the co-ordinating system in ARDS 
patients are primarily a result of either changes in the terminal system 
or transport system (vide 4.3); it could not, therefore, contribute 
significantly towards the understanding of the fundamental 
pathophysiology of the syndrome. 
Ideally the model should incorporate the co-ordinating system and a 
detailed analysis of the transport system; in this specific application 
the knowledge gained would not, however, justify the effort of such an 
undertaking. 
The lines of thought and sequence of analytical procedures followed 
during the design of a mathematical model are depicted in Fig. 5.1. An 
appropriate hypothesis of ARDS pathophysiology was first decided on, 
after which the model design was guided by this hypothesis. 
DESIGN EXPERIMENT AL DESIGN MATHEMATICAL 
PROTOCOL loaliia--~ MODEL OF BIOLOGICAL 
REFORM MEASURE= 





MODEL VALIDATED OVER 
LIMITED PHYSIOLOGICAL 
RANGE 
PRESENT A HYPOTHESIS FO 
DESIGN EXPERIMENTAL 1.-~-----1 THE PATHOPHYSIOLOGY 
PROTOCOL 
PERFORM MEASURE= 
MENTS ON PATHOLO= 
GICAL SYSTEM 
SIMULATE PATHOLOGY 
ON THE MODEL 
HYPOTHESIS V AUD 
OVER LIMITED RANGE 










Figure 5.1 Diagrarrmatic representation of the modelling and 
simulation process for biological systems. 
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Hypothesis l 
A correlation exists between the onset and severity of ARDS in human 
beings and the nature or shape of the ventilation/perfusipn distribution 
in the lung. 
A diagramatic representation of the model developed for simulating gas 











inspired air flow [1/min] 
partial pressure of inspired gasses [mmHg] 
alveolar air flow [1/min] 
alveolar partial pressure [mmHg] 
expired air flow [1/min] 
partial pressure of expired gasses [mmHg] 
venous blood flow [1/min] 
pulmonary capillary blood flow [1/min] 
arterial blood flow [1/min] 
arterial gas concentration [ml/l(X) ml blood] 
venous gas concentration [ml/100 ml blood] 
pulmonary capillary blood concentration [ml/l(X) ml blood] 
amount by which the P50 (at 37°c, pH== 7,4, PC02 == 40 mmHg) of 
the subject's blood exceeds the standard of 26,8 mmHg. 
PB Barometric pressure [rrmHg] 
PH20 Va.P)ur pressure [mmHg] 
The model depicted in Fig. 5.2 can be combined in a multi-compartmental 
gas exchange model according to the ventilation-perfusion distribution in 
the lungs. Fig. 5.3 depicts the complete model, representing N 
compartments of the gas exchange uni ts, with ventilation and perfusion 
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Figure 5.3 Block diagram of a N-canpartmental 
pulmonary gas exchange model. 
Model Assumptions 
a. The model is time invariant and therefore represents a steady state 
condition of gas exchange in the lungs, i.e. no cyclical variations 
in air or blood flow are considered. 
b. The functional gas exchange uni ts (i.e. the alveoli and pulmonary 
capillaries) are represented as a series of N different compartments 
within the lungs, with varying ventilation-perfusion ratios. 
c. The alveoli, capillaries and the respective blood and air flow to a 
single canpartment are uniform. 
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d. A state of equilibrium between the blood and gas phase is reached 
instant.aneously, disregarding possible diffusion impairments and 
time dependant biochemical reactions in the blood. 
e. The alveolar and end-capillary partial gas pressures are assumed to 
be equal in a specific compartment. 
The model is non-linear with multi-variable inputs and outputs, with a 
working point that is a function of various physiological variables, i.e. 
the "transfer function" is a function of the model variables. With this 
in mind, it is possible to adopt the model for a specific biological 
system and therefore create a unique model for a specific patient under 
investigation. 
5.2.1 Model equations: The lung was sub-divided into N different compart-
ments, with respective air and blood supplies, each compartment is solved 
according to the Fick principle (the conservation of mass in a system), 
the compartments being finally summed to obtain a picture of the resul-
tant gas exchange in the 1 ungs. 
The equations used in the model developed by the author to study gas 
exchange in the lung were acquired from a model originally designed by 
West (1969). 
Similar to West's model, the exchange of nitrogen was incorporated, which 
adds considerably to its complexity; the resulting error when neglecting 
nitrogen gas exchange increases under conditions of a high fraction of 
inspired oxygen as well as in regions of very low ventilation-perfusion 
ratios (both conditions which are simulated with the model). 
The system equations pertaining to gas transfer in the lungs are based on 
the Fick principle, i.e. the conservation of mass of the individual 
respiratory gases (Olszowka and Farhi, 1969; West, 1977). 
5.2.1.1 System Equations: 
. 
K.Qi. [Ca02i - CV02] VAii F102 VAi FA02i = . . 
K.Qi, [Ca0)2i - CV0)2] VAii Fr0)2 - VAi FA0)2i = . 
K.Qi. [CaN2i - CyN2] VAii F1N2 - VAi FAN2i = 
- Fick principle 
- Daltons Law 
FA02i + FACX)2i + FAN2i = 
F102 + Fr0)2 + F1N2 = 
1,0 
1,0 







< Q.CyG BLOOD PHASB C, 
INPUT = OUTPUT 















Equilibrium with no gas concentration difference is assumed between the 
gas and blood phases for a single compartment; furthermore the mass input 
of a specific respiratory gas into the compartment equals the mass output 











inspired alveolar ventilation 
alveolar ventilation (resultant) 
fraction of inspired gas concentration 
fraction of alveolar gas concentration 
pulmonary capillary perfusion 
arterial gas content 
mixed venous gas content+ (pulmonary artery) 
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refers to compartment number (total number of compartments : 
N) 
BTPS to STPD conversion factor (0,0121) 
The resultant gas exchange in a gas exchange unit equals the difference 
between the arterial gas content and the mixed venous gas content (Fick's 
principle). The sum total of the respiratory gas exchanged equals the 
sum total of the gas exchanged in the indi victual compartments; this is 





Qi.[Ca02i - Cv02] ::; V02 (5.6) 
i ::; 1 
N 
2 Qi, [CaC02i - <;CO2] ::; VC02 (5.7) 
i ::; 1 
N 
2 Qi, [CaN2i - CvN2] 
. 
::; VN2 (5.8) 




Q. ::; Q 
]. (5.9) 




VAi ::; VA (5.10) 
i ::; 1 
total oxygen consumption 
total carbon dioxide output 
total nitrogen exchange 
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total pulmonary perfusion (cardiac output - anatomical 
shunts) 
total alveolar ventilation (minute volume - anatomical dead 
space) 
The arterial and mixed alveolar gas concentrations are the weighted 




Ca02 = Qi.Ca02i (5.11) 




Ca(X)2 = Qi .CaC02 (5.12) 




CaN2 = Qi.CaN2 (5.13) 




PA02 = VAi'PA02i (5.14) 
i = 1 VA 
N 
PA(X)2 = 2 VAi'PA(X)2i (5.15) 




PAN2 = VAi'PAN2i (5 .16) 
i = 1 VA 
The ideal gas point is calculated by assuming one uniform gas exchange 
canpartment: 
gas content 
gas content at ideal gas point 
arterial gas content 
alveolar partial gas pressure. 
(5.17) 
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5.2.1.2 Blood - Gas interphase (transfer function) 
(a) Oxygen - Haemoglobin dissociation curve 
The blood oxygen concentration (C~2) is a function of the oxygen partial 
pressure (FD2) and other related physiological variables 
FD2 = f (TEMP, pH, PCD2, DP50) 
802 = f (FD2) 
C~2 = f (002, HB, S04)2) 
002 haemoglobin oxygen saturation 
SOLc) 
2 solubility of oxygen in blood 
Various sets of curve fitting equations have been described for the 
oxygen - haemoglobin dissociation curve (Severinghaus, 1966; Olszowka & 
Farhi, 1968; Kelman, 1966, 1968) and more recently Winslow et al. (1983), 
incorp:>rating in more detail the effect of DPG. 





.10 [0,024.(37-TEMP)+o,4.(pH-7,4)+0,06.(log 40-log PCD2)] 
(5.18) 
This equation compensates for acid-base and temperature disturbances from 
the standard FD2 which would have been obtained at a pH of 7,4 and a PCD2 
of 40 rrm Hg. 
FD2 virt1 . 26,8 
FD2 virt 2 = 26,8 + DP50 
(5.19) 
Equation (5.19) was subsequently added in West (1977) to compensate for 
additional shifts such as caused by an increased red cell concentration 
of 2,3 DPG. 
DP50 the amount by which the P50 of the subjects blood exceeds the 
P50 of the standard dissociation curve (26,8 mm Hg). The P50 of the 
patient must be known at 
TEMP = 37°c pH = 7,4 PCD2 = 40 rrm Hg 
X = FD2 virt2 
IF X > 10 rrm Hg then: (5.19a) 
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al = -8,53222 89 X 103 
a2 = 2,12 14010 X 103 
a3 = -6,707 3989 X 101 
a4 = 9,359 6087 X 105 
a5 = -3,1346258 X 104 
a6 = 2,396 1674 X 103 
a7 = -6,7104406 X 101 
(5.21) 
IF X < 10 nm Hg then: 
S02 = 0,003683. X + 0,000584.X2 (5.22) 
These equations (5.21, 5.22) have subsequently been added by Kelman 
(1968) to describe the region of the curve below a F02 of 10 mm Hg. 
F02 virt virtual oxygen partial pressure [nm Hg] 
so2 haemoglobin oxygen saturation [ % ] 
TEMP 
blood oxygen content 
haerribglobin concentration 
solubility of oxygen in blood 
normal value : 0,003 
blood temperature 
[ml02/100 ml blood] 
[g/100 ml blood] 
[ml02/100 ml - mm Hg] 
(b) Carbon Dioxide dissociation curve 
The carbon dioxide blood content is dependant on the PC02 and other 
related physiological variables : 
C-CD2 = f (P(X)2, pH, so2, HCRIT, TEMP) 
An algorithm for the conversion of P(X)2 into blood (X)2 content, developed 
by Kelman (1967), was used in the model design : 
p 
pK 
= 7,4 -pH 




TEMP = 37 - TEMP (5.25) 
SOLco 
2 = 0,0307 + 0,00057 • TEMP+ 0,00002 • TE~ (5.26) 
oox = 0,590 + 0,2913. P - 0,0844. P2 (5.27) 
DR = 0,664 + 0,2275.P - 0,0938. P2 (5.28) 
D = DOX + (DR-OOX) . (1 - 3)2/100) (5.29) 
CP = 80Lco2-PCD2 .(1 + 10 (pH - pK) (5.30) 
cc = D . CP 
C-CD2 = [HCRIT . CC+ (1 - HCRIT) . CP] .2,22 (5.31) 
blood carbon dioxide content [ml 02/100 ml blood] 
solubility of carbon dioxide in blood [mlCD2/100 ml blcx:xi -
mm Hg] Normal value = 0,0017 
HCRIT heamatocrit 
(c)pH - pCQ2 relationship 
= 0,003 . HB. (1 - S02/lOO) (5.32) 
APR compensates for the shift of the blood buffer line which occurs when 
the haemoglobin is reduced (Kelman, 1968). 
pH = 7,59 + APH - 0,2741 log (PCD2/20) (5.33) 
The pH is obtained from the Siggard-Anderson pH-log PCD2 diagram (West, 
1977). 
(d) Nitrogen - blcx:xi dissociation 
The amount of nitrogen dissolved in blcx:xi is in accord with Henry's law: 
= so~ 2 
C-N 2 nitrogen blood content [mlN2/100 ml blood] 
(5.34) 
S0~2 solubility of nitrogen in blood [m1N2/100 ml blood - mm Hg] 
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5.2.2 Ventilation-Perfusion ratio distribution: The ventilation and perfu-
sion to each one of the individual gas exchange compartments in the model 
must be specified in order to solve the systems equations; a log normal 
distribution for both the ventilation and perfusion distributions was 
asswned. 
The major considerations were "physiological compatibility" and suffi-
cient freedom to manipulate the distributions in order to simulate patho-
logical conditions, especially those related to ARDS (vide 4.4). 
As for the physiological considerations, a similar distribution function 
was chosen by Farhi and Rahn (1955) for their theoretical analysis of the 
alveolar-arterial oxygen pressure difference (P(A-a) o2). More recently, 
in experiments determining the blood flow and ventilation in the lungs 
(Lenfant & Okubo, 1968; Okubo & Lenfant, 1968; Wagner et al., 1974; 
Dantzker et al., 1979), it appears that the actual distribution in the 
lungs broadly resembles that of a log normal distribution. 
It should be noted, however, that the distribution function remains only 
a theoretical representation of the actual lung physiology; furthermore, 
direct anatomical parallels should be attempted with caution since the 
measuring process does not always contain information related to the 
spatial distribution of blood and air in the lungs. 
Mathematical model: The respective distributions are derived from the 
standard equation for a log normal statistical distribution, i.e. 
Xi - u 
)2] [-0,5 ( 0-
Yi 1 . e (5.35) = fT . .J2:'i'f' 
Yi = volume of compartment number i 
Xi = log flow/unit volume in compartment i 
TI = log mean flow/unit volume 
(T = log standard deviation of flow 




Flowi = total flow (Q, VA) (5.37) 
i = 1 
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Remarks: 
(a) The flow represents either the ventilation or perfusion. 
(b) The distributions are modified such that the total ventilation or 
perfusion equals that specified for the model. 
(c) The lung canpartments are spaced equidistantly on the log X-axis. 
(d) Both sets of compartments (ventilation and perfusion) are numbered 
from left to right on the X-axis and matched accordingly to obtain 
the VA/Q for a specific compartment. 
(e) A bimodal distribution may be specified for either the ventilation 
or perfusion distributions or both, in which case the resultant 
distribution is the arithmetic sum of two separate log normal 
distributions (the flow ratio of the two distributions is 
specified). 
(f) The total number of compartments is specified and is always equal 
for both the ventilation and perfusion distributions. 
(g) The distributions are discrete and contain discrete points (either 
ventilation or perfusion) for each one of the compartments. (When-
ever represented as a continuous curve it is for aesthetic reasons 
only). 
5.2.3 Physiological Shunt and Dead Space: The concept of a shunt in the 
pulmonary circulation has been firmly established in physiological re-
views and clinical practice. However, it is not always appreciated for 
what i .t is and sometimes unduly contributes towards confusion in the 
process of clinical decision making. 
Various shunts have been defined in the past which further contributes 
towards the confusion. For the purpose of this thesis, the physiological 
shunt or venous admixture is defined as that percentage of venous blood 
mixed with the arterial blood that would cause the measured difference 
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between the actual arterial oxygen content and the ideal arterial oxygen 
content. The ideal arterial oxygen content would be obtained when all 
gas exchange uni ts within the lung have a ventilation-perfusion ratio 
equal to V A/Q and no diffusion impairment exists, i.e. the optimum gas 
exchange is affected for a specific combination of total alveolar 
ventilation and pulmonary perfusion. 
The physiological shunt can be calculated as follows 
Crn02 - Ca02 
CrrP2 - ~2 
blood flow that is shunted 
total venous return or cardiac output 
ideal arterial oxygen content 
The physiological shunt can be ascribed to two major effects 
(5.38) 
(a) That portion of venous blood that never has any contact with the 
alveolar septum and consequently does not partake in the gas 
exchange process, not even in the case of the completely healthy 
lung. This percentage is due to the blood flow in the Thebesian and 
bronchial veins and is usually referred to as the anatomical shunt. 
(b) The other factor contributing towards the physiological shunt is the 
effect of ventilation - perfusion mismatch in the gas exchange 
units. The concept of ventilation - perfusion mismatch is 
illustrated in Fig. 5.5. 
< ·> .a - -= = .Sl 0 ... -~ 
~ .... ... .. 
= & V 
> >-.. .. s ~ 
8 0 
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contributes towards 
a physiological shunt 
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alveolar dead space 
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Figure 5.5 Illustration of a ventilation/perfusion mismatch 
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Point (A) represents atelectatic alveoli (unfortunately this is sometimes 
also referred to as part of the anatomical shunt) and point (C) repre-
sents total pulmonary capillary occlusion or constriction. The ideal 
ventilation-perfusion ratio for a specific lung would be VA/Q; any ratio 
less than it would contribute towards shunt-like effects due to a venti-
lation-perfusion mismatch. It is of the utmost importance to realise 
that the actual ventilation-perfusion distribution in the lung resembles 
a continuous distribution and all the gas exchange units with a ventila-
tion-perfusion ratio less than the ideal ratio will contribute towards 
the physiological shunt. 
The concept of the physiological dead space is analogous to the 
physiological shunt, except that in this case the transport medium is the 
ventilatory gas and all the gas exchange units with ventilation-perfusion 
85 
ratios greater than the ideal ratio, contribute towards the physiological 
dead space. 
Physiological Dead space = Anatomical dead space+ dead space due to 
VA/Q inequalities (alveolar dead space). 
(5.39) 
The physiological dead space percentage can be calculated with the Bohr 
equation: 
. 
Vos/ = PACD2 - P_in2 . 
/VT. PACD2 
airflow through the physiological dead space 
total ventilation (minute volume) 
expired carbon dioxide patial pressure 
alveolar carbon dioxide partial pressure 
(5.40) 









VoA/ = P10CD2 - PAC02 
/VA P10CD2 - P1CD2 
ideal alveolar carbon dioxide partial pressure 
mixed alveolar cn2 
inspired CD2 partial pressure 
air flow through the alveolar dead space 
total alveolar ventilation 
(5.41) 
5.2.4 Computer Simulation Program: The software was developed as an experi-
mental package exclusively and not for general use or educational pur-
poses. Software was written in TUR.B'.) PASCAL (VERSION 3) and simulations 
were performed on an Olivetti M24 microcomputer with a floating point co-
processor. 
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The program flow chart, combined with the detailed sequence of calcula-
tions (program algorithm) provided in Table 5.1, should however facili-
tate development of a similar software package in any other computer 
language. 
The complete program should be treated as a subroutine with input and 
output parameters as specified in Appendix A. A master simulation pro-
gram was used to change the input variables of the subroutine in order to 
simulate specific physiological conditions in the respiratory system. 
Fig. 5.6 represents the general program flow chart and should be read in 
conjunction with Table 5.1, describing the sequence of program calcula-
tions. The system of non-linear simultaneous equations as depicted in 
Table 5.1 is solved employing the Newton Raphson method (Appendix B); 
this technique was favoured due to its inherent matrix structure and ease 
of operation once the equations are simplified and configured in the 
appropriate matrix structure. 
A detailed discussion of the software and problems encountered during the 
development phase is not justified; these are usually specific to the 
computer system or the numeric techniques employed and would not 
elucidate any of the simulation equations or underlying physiology. 
It must, however, be stated that a considerable amount of time, in 





(Newton Raphson method) 
'J 
N 
Generate: VA and Q 
distributions for N- compart= 
ments respectively 
Specify: input-, output-, 
and system variables 
' 
1st guess: 
Solve: gas exchange 
compartments I to N 
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The mathematical model as discussed in the previous chapter was applied 
as an iterative subroutine in a master simulation program to generate a 
series of simulations. 
Different solutions for the bloos gas pressures (i.e. Pao2, PV02, Pam2, 
Pvm2, PaN2, P~2) exist for each set of model parameters. It is rather 
obvious that through structured variation of the model parameters, the 
respective solutions can be obtained and the effect on the blood gas 
pressures observed. 
The number of combinations by which a set of model parameters can be 
selected is limited only by the physiological range of the respective 
parameters. In practice selection is biased by the prospective clinical 
application of simulations. 
6.2 SIMULATION METHOD 
A series of simulations was completed according to the flow chart 
presented in fig. 6.1. The respective model parameters (correlating in 
most instances with actual physiological variables) as well as the VA/Q 
distribution parameters were specified and held constant for the duration 
of a single simulation procedure. 
For each of the simulation procedures, two or three of the above-
mentioned parameters were however varied iteratively over a limited 
range; producing a set of solutions in either two or three dimensions. 
The VA/Q distributions generated as an input for the model were altered 
by equating a distribution parameter with one of the parameters varied in 
the simulation program. The actual shape of the ventilation/perfusion 
distribution is in fact the entity that bears the most clinical signifi-








Specify model parameters 
Specify V AIQ distribution 
rameters 
Specify variable 1 
initlal value 
Specify variable 2 
initial value 
Specify variable 3 
initial value 
Solve blood 
PaO gas values 
1 
END SIMULATION 
Figure 6.1 Flow chart for master simulation program 
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6.2.1 YA/Q Distributions: VA/Q distributions were generated at discrete 
intervals between two extreme cases; i.e. a distribution with a single 
mode represented by a mean V A/Q of 0,85 and the state of an additional 
mode with a mean VA/Q that is markedly lower. (The mean VA/Q value of 
the lesser mode is subsequently referred to as the low VA/Q value.) 
The intermediate distributions were generated by increasing the amount of 
blood and air flow to the low V A/Q region, starting at zero. The mean 
VA/Q values for the two modes were held constant, as well as the combined 
pulmonary perfusion to the two regions. 
In order to realise these conditions it is inevitable to tolerate a small 
decrease in the total alveolar ventilation with a concomitant increase of 
perfusion to the low region. (The low VA/Q value would otherwise change 
as a result of the perfusion change in this region.) The decrease in 
alveolar ventilation is nevertheless physiologically justifiable, as it 
is analogous to increased pulmonary oedema, resulting in an effective 
decrease in ventilation to these regions and a percentage increase in 
perfusion. 
Two separate series of distributions were considered with respective low 
VA/Q values of 0,124 and ~,003 and a veriation of the blood and air 
supply (as discussed) for both cases. Although variations inbetween the 
two low VA/Q values were not explicitly addressed, it is assumed that the 
majority of distributions for ARDS patients, or those susceptible to 
ARDS, will be within the boundaries represented by these two series (i.e. 
a perfusion to the low VA/Q region of Oto 55% of total pulmonary perfu-
sion and a low VA/Q value of inbetween 0,003 and 0,124). This assumption 
will be elucidated in the discussion pertaining to graph 7.2. 
Three of the distributions in the series with a low V A/Q value of 0,003 
are represented in graphs 6.1, 6.2 and 6.3; with respective percentages 
of total pulmonary perfusion to the low region of 0%, 27,5% and 55%. 
Graphs 6.1, 6.4 and 6.5 represent the corres.{X)nding distributions in the 
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6.2.2 Simulation Strategy: The simulations are divided into two major cate-
gories, namely those pertaining to a low V A/Q value of 0,003 and 0, 124 . . 
respectively. (The low VA/Q value is specified as one of the model 
parameters.) 
Furthermore the percentage of total pulmonary perfusion to the low VA/Q 
region is varied between 0% and 55% and is, with reference to fig. 6.1, 
represented by variable 2. 
In all instances, the fraction of inspired oxygen is varied from 0,21 to 
0,99 and is, with reference to fig. 6.1, represented by variable 3. 
The data series representing the arterial oxygen partial pressure as a 
function of both the fraction of inspired oxygen and the percentage of 
total pulmonary perfusion to the respective low VA/Q regions, are consi-
dered to be the model outputs bearing the most useful information. (In 
these cases variable 1, with reference to fig. 6.1, is held constant.) 
The following values were assigned to the various model parameters and 
were kept constant for each simulation (except for the sensitivity analy-
sis, in which case one parameter was varied at a time). Simulations 





ii) Solubility of o2 in blood 
iv) Temp 
v) HB (venous and arterial) 
vi) Solubility of N2 in blood 
vii) DP50 
viii) K (BTPS to STPD factor) 
ix) HCRIT 
x) PEF (effective gas pressure) . 
xi) V02 
xii) vm2 
xiii) VN2 . 
xiv) VA 
xv) Q 
xvi) number of lung canpartments 
Value 
0,0 



















[ml02/100ml - lIIIIHg] 
[oC] 
[g/lOOml blood] 








xvii) FI02 0,21 to 0,99 [fraction] 
xviii) VA/Q distribution parameters as discussed 
Graphs 6.6 to 6.9 were generated by the model with the abovementioned 
techniques. 
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6.2.3 Parameter Sensitivity Analysis: In order to investigate the effect of 
variations in model parameters on the model outputs, all the parameters 
were varied one at a time (variable 1 with reference to fig 6.1) and a 
new set of solutions thus obtained. 
The above-mentioned exercise was repeated twice; in the one instance the 
range of variations in the physiological variables was selected to repre-
sent the most extreme conditions compatible 1,v L t h life. This series is 
represented by graphs 6.10 to 6.25. 
In the second instance a 10% deviation around what are considered to be 
the mean values was induced. The results are SUlllilarised in Appendix C. 
It is noteworthy that due to the nonlinear nature of the model, it is not 
J;X)Ssible to assume that the effect of a change in more than one of these 
parameters at a time will result in the sum total of the effect of the 
individual changes. Due to the limitation on computer processing speed 
(the average computer runtime is 2 hours and 12 minutes for a single 
simulation), it is not practical to investigate different combinations at 
this stage. 
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CLINICAL APPLICATI<n OF mE IDK.. 
7.1 INTRODUCTION 
A great deal has been said in the preceding chapters about related 
physiology, mathematical modelling and the actual simulation results; it 
would have been a rather luxurious exercise if no further useful 
information was derived fran the model under discussion. 
One of the applications of modelling, which sometimes unfortunately 
passes unnoticed, is the educational value it contains for those with a 
thorough understanding of the underlying mathematics contained within it. 
Interrelationships between the various physiological parameters, causa-
lity principles (i.e. relationship between cause and effect) and the 
aspect of supply and demand of the entities under investigation are 
elucidated; additional insight is gained into the problem and occasional-
ly it may even lead to new discoveries. 
It is not, however, always possible to invest the required time to study 
a model in detail, or the user may even lack the necessary specialised 
training to attempt it. It is therefore of great benefit if an easy-to-
use algorithm which bears some clinical relevance can be extracted from 
the model; to be applied by the user without substantial knowledge con-
cerning the underlying theory. 
Such a method was developed by the author and is discussed in the 
following section; if feasible at all, the model (as discussed in Chapter 
5) should be studied in conjunction with the simplified algorithm. 
7.2 INTERRELATEDNESS OF PARAMETERS AND THE CLINICAL RELEVANCE OF THIS RELA-
TIONSHIP 
A few interesting points from the simulation results in Chapter 6 deserve 
mentioning. 
With reference to graphs 6.20 to 6.25 it is clear that maximal changes in 
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haemoglobin concentration, blood temperature and haematocrit will affect 
the arterial oxygen pressure to a negligible extent (less than 10% change 
in Pao2 for a maximum change in these parameters respectively). The same 
can be said for the carbon dioxide output (graphs 6.12 and 6.13). 
Another interesting fact is that an increase of 100% in the total alveo-
lar ventilation, results in a maximum increase of 10% for the Pao2• In 
the case of a low V A/Q value of 0,003 the effect is even less. This is 
of major clinical significance, since it implies that an increase in 
minute ventilation for the ARDS patient will contribute only marginally 
towards the improvement of the Pa02 level (graphs 6.14, 6.15 and Appendix 
C8). 
The parameters with a substantial effect on the Pa02 level are the effec-
tive inspired pressure (PEp), oxygen consumption (V02) and the total 
pulmonary perfusion (Q); graphs 6.18, 6.19, 6.10, 6.11, 6.16 and 6.17 
· illustrate this point. 
At a F1o2 of 1,0 an increase in PEF can be as high as an equal increase 
in the Pao2; the proportionality constant decreases with a worsening in 
the V A/Q distribution. This is a well known fact and is one of the major 
therapeutic measures for the ARDS patient. A direct effect of PEEP is to 
increase the PEF; it does also improve the VA/Q distribution, which has 
an indirect and probably more marked effect on the Pao2 level. 
The effects of vo2 and Qare directly interrelated, which is partially 




Qi [Ca02 - Cv021 = V02 (5.6) 




Qi = Q (5.9) 
i = 1 
. 
The (Ca02 - evo2) difference relates the respective Qi com!X)nents and the 
total oxygen consumption. Due to the unequal distribution of blood in 
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the lung, depicted by the VA/Q distribution and summation component in 
5.6 and 5.9, the relationship is non-linear. It is tempting to argue 
that if vo2 is held constant and Q is increased; the (Ca02i - Cv02) 
difference must decrease and will therefore result in a decrease of eao2. 
The opposite is however true, although the (Cao2 - c;;o2) difference 
decreases, the sum total of Ca02i will increase, matched by an increase 
of the Pvo2 level. 
It follows from graphs 6.16 and 6.17 that for vo 2 held constant, an 
increase in Q will result in an increase in Pao2 (the magnitude of which 
increases with a worsening of the V A/Q distribution). In the case of a 
severe VA/Q mismatch, i.e. a low VA/Q of 0,003 and 55% of the total 
perfusion to the low region, the effect of an increase in Q is less 
marked (graph 6.17). The same can be said for a constant Q and a 
decrease in o2 (graphs 6.10 and 6.11). In practice an increased cardiac 
output, caused by a factor which will also substantially influence the 
VA/Q ~istribution, may fail to elicit the desired increase in Pao2. 
The oxygen consumption normally increases for ARDS patients due to an 
.increased metabolic rate; the fact that it sometimes shows a decrease can 
be ascribed to a decrease in the supply and not the demand (Danek et al, 
1980). A decrease in the oxygen supply may be due to a decrease in the . 
cardiac output (and therefore Q). The concept of cause and effect are 
thus clearly illustrated through this example. 
It is noteworthy that apart from the inspired oxygen concentration and 
the effective inspired pressure, the cardiac output is the only 
physiological parameter that can be manipulated with a significant effect 
on the arterial oxygen content and therefore the oxygen supply. 
t ~ow Y/Q = 0.003 I --- I 1 10w Y/Q - 0 . 003 I I 1 10w Y/Q a 0 . 003 I I 128 · C/blood • 41.2 ti) 7 7 L/blood • 20.6 ti) 4---4 L/ blood = 0 t.1J 1---1 
I low Y/Q • 0.003 t .. . , ,---a I I low Y/Q = 0.003 r··- 1 ~---s 11 10111 Y/Q • 0 . 003 , 2 ___ 2 , . L/ blood = 48.i IJ. . . L/ blood • 27.5 I). . . L/ blood • 6 . 9 fl]. . 
I 



















A. = C) Ul Q C) 
ARTERIAL OXYGEN PARTIAL PRESSURE [mm Hg] 
O') = C) 
1








jj ~ lo-w -Y /-Q -. -0. -124-. . -, 1-=-------.
1 
j 
. L/blood = 41.2 CIJ . . . L/blood • 20.6 C.11 . . . L/blood .. o (%] . . 
I low Y/Q ... 0.124 . .' j a-e j j low Y/Q • O.i24 ·_ - j s--51 j low Y/0 • 0.124 t j 2-2 \ _L/blood • 48 . i fl]. . _L/blood .. 27 . 5 f.lJ. . _Ublood ... 6.9 I]. _ 
I low Y/Q = 0 . 124 · ~ , 9_9 j j low Y/Q • 0.124 , j s-e j j Iow Y/0 • 0.124 j 3_3 I . L/blood .. 55 [%] . . . L/blood • 34 . 4 [IJ . . . L/blood .. 13 . 7 [%) . . 
129 
. . 
7.3 :f..A/Q DISTRIBUTION 
The reasons for selecting, and the clinical relevancy of the two dif-
ferent types of VA/Q distributions used in the simulations are discussed 
r.... in this section. 




The results in graph 7.1 are a superposition of both of the bimodal 
distribution types used (i.e. graphs 6.6 and 6.7 combined) and represent . . 
the two extreme cases of VA/Q distributions for the ARDS syndrome. 
A maximum percentage of pulmonary perfusion to the low VA/Q area of 55% 
were chosen in both instances. The reason for this is because a 
physiological shunt of 50% seems to be the maximum observed in ARDS 
patients (Covelli et al, 1983; Ralph and Robertson, 1981). 
The series of FI02, Pa02 curves (graph 7.1), representing the low V A/Q 
value of 0,124 is analogous to _the situation of alveoli partially filled 
with fluid; at a high FI02 of 1,0, maximum oxygen-transfer can still be 
obtained. This is a result of the sigmoidal shape of the oxygen-
haemoglobin dissociation curve. 
On the other hand the series of Fio2 , Pao2 curves (graph 7.1) 
representing the low VA/Q value of 0,003 is analogous to a situation of 
alveoli filled with fluid to such an extent that maximum oxygen transfer 
cannot be achieved any more, even at the high FI02 value of 1,0. 
The following assumptions were made regarding the two series of VA/Q· 
distributions: 
. . 
(a) The VA/Q distribution in any ARDS patient or patient susceptible to 
the ARDS syndrome can be represented by a combination of the two 
series as discussed. 
. . 
(b) The sequence of changes in the VA/Q distribution for a healthy 
patient to a susceptible patient and finally to confirmed ARDS, will 
be from a unimodal distribution to a bimodal distribution with a low 
VA/Q value 0,124 to a bimodal distribution with a low VA/Q value of 
0,003. The transformation is not discrete, but will at any moment 
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in time result in a distribution which can be represented by a 
combination of the two conditions as illustrated in graph 7.1. 
(c) The relative clinical significance of the two series is related as 
follows: 
The severity of a situation of 55% of total pulmonary perfusion to a 
low V A/Q region of 0, 124 is equal to the severity of a 21% of total 
pulmonary perfusion· to a low VA/Q region of 0,003 (lines 9 and 4 in 
graph 7.1). Al though the arterial oxygen content at an FI02 of 1,0 
is relatively high in the first instance compared to the second, it 
must be noted that a much higher percentage of blood is distributed 
to the low V A/Q region in the first instance (it is analogous to a 
situation of relatively mild but widely dispersed oedema compared to 
relatively localised but severe oedema). 
The justification for the respective low VA/Q values of 0,124 and 0,003 
is explained by the results of graph 7 .2. In this particular case the 
percentage perfusion to the low VA/Q region was kept constant at 53% and 
the low VA/Q value was varied (which is representative of a shift in the 
mean of the low V A/Q mode). It can be observed from this graph that a 
low VA/Q value of 0,124 represents the cut-off point where the Pa.02 at a 
FI02 of 1,0 starts to decrease from the maximum value observed at this 
point in normal unimodal VA/Q distributions (a decrease of 10% from the 
maximum value). Furthermore the low V A/Q value of 0,003 represents the 
distribution where there is no notable increase in Pao2 from a FI02 of 
0,21 up to 1,0. 
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7.4 THE PHYSIOL03ICAL SHUNT AS A DIAGNOSTIC INDICATOR 
The physiological shunt is widely used as a diagnostic indicator in 
patients suffering from VA/Q mismatch in the lung and therefore also in 
the case of ARDS patients. Although it is a useful concept, it does have 
certain limitations and may in some instances result in a serious miscon-
ception of the problem. 
This point is illustrated in graph 7.3. It is clear that the 
physiological shunt for the series with a low V A/Q value of 0, 124 is a 
function of FI02• For example line 9 (lo.w V A/Q = 0,124) varies from a 
48% to a 1,5% physiological shunt, depending on FI02• It was previously 
explained that this case, insofar as the condition of the V A/Q 
distribution is concerned, is equivalent to line 4 (low VA/Q = 0,003) 
which has a nearly constant physiological shunt of 20% over the entire 
Fio2 range. 
For a patient with a distribution of a low VA/Q value= 0,124, the shunt 
measured will therefore either give a too high or too low indication of 
the state of the VA/Q mismatch; depending at which FI02 it is measured. 
Physiological shunt measurements are normally done at a FI02 level of 
1, 0, which will create a false impression of safety for the low V A/Q = 
0,124 series. 
. . 
It is true that once the low VA/Q = 0,003 phase has been reached, i.e. an 
established ARDS syndrome, the physiological shunt will serve as an 
accurate indicator; during the preceding phases this will not be the 
case. This may even explain the reason for the apparent "sudden onset" 
of the ARDS syndrome; since the method employed to calculate the physio-
logical shunt is not sensitive enough to detect the underlying ventila-
tion/perfusion inequalities already in progress in the early stages of 
the syndrome, only once the low VA/Q = 0.003 phase has been reached does 
it succeed in detecting the abnormalities. 
At this stage it should be clear to the reader that there is only one 
reliable indicator of the condition of the lung during all stages of the 
clinical course and that is the actual shape of the VA/Q distribution 
itself. 
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7.5 PARAMEI'ER IDENTIFICATION TECHNIQUE 
Mathematical modelling of complex systems is closely related to the 
technique referred to in engineering terms as parameter identification. 
From an engineering lX)int of view any system can be subdivided into a set 
of input variables, a set of system parameters and a set of output 
variables. The system parameters are normally contained within the 
transfer function, which relates the output variables to the input 
variables. 
In this particular model, the transfer is represented by all the 
equations as discussed in Chapter 5 and the parameters are those values 
as discussed in 6.2.2. and Appendix A. 
A technique is often used in engineering whereby the input variables are 
varied (normally in the form of a step reslX)nse) and the related changes 
in the output variables are then observed. Either the dynamic or stabi-
lised changes in the output variables are observed; these are referred to 
as the transient and steady state characteristics respectively. Through 
observation of these changes, unknown parameters contained with in the 
transfer function can be identified. Figure 7.1 illustrates the point 
for the specific model as discussed. In this case there is a single 
variable input (i.e. FI02) which can be changed in discrete steps between 
0,21 to 1,0 (step input) and a single variable output (i.e. Pa02). The . . 




'Ii 7 ~7 
INPUT .... TRANSFER FUNCTION OUTPUT "' 
- ... "" F10z (Respiratory system) PaOz 
Figure 7.1 Respiratory Input/Output system. 
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The information that can be obtained about the system by using these 
techniques is superior to any conventional clinical measuring techniques 
where very little sophisticated processing techniques are applied (for 
example the physiological shunt measurement). 
The model developed is not time-dependent and therefore only simulates 
steady-state conditions (i.e. the exact nature of the increase in Pa02 
inbetween the time periods related to an increase in F1o2 is not 
addressed) • 
A simplified flow chart of a method to identify the V A/Q distribution 
parameters and therefore the shape of the distribution, is presented in 
Fig. 7.2. The ideal, would be to increase the F1o2 for the patient in 
steps of 0,2 and in each instance to measure the Pao2 as well as all 
those physiological parameters as required by the model. The model is 
then simulated through a series of iterations until such time that the 
output matches the data as measured in the patient; the likely shape of 
the VA/Q distribution within the patient will then be intimated. 
Due to a limitation on the processing time of computers, it may not be 
feasible to go through this complete sequence at this stage, unless 
dedicated access to an ultra fast computer is available. Another dis-
advantage is the number and frequency of measurements required. Bearing 
in mind that automatic measuring equipment may not be available and the 
nature of the ICU environment, it is unlikely to be feasible to attempt 
these consecutive measurements every time the shape of the VA/Q distri-
bution needs to be determined. 
Alternatively a few assumptions can be made that greatly simplify mat-
ters: 
(a) Only one set of parameters need be measured at the beginning of the 
Pao2 measurements and it is then assumed that they remain relatively 
constant during the preceding changes in F1o2• Alternatively, the 
parameters may not be measured at all and the standard set of values 
(as discussed in 6.2.2) can be used. 
(b) Only three Pao2 measurements need be made, at F1o2 equal to 0,5; 0,8 



















































(The implications of these assumptions are discussed in a subsequent 
section.) 
If only three Pa02 measurements are made on a patient at a FI02 of 0,5; 
0,8 and 1,0, the points can be plotted onto Graph 7.1 and, depending on 
its position, an indication can be obtained of the shape of the VA/Q 
distribution in the patient. (The standard set of parameters is as-
sumed.) Alternatively, one set of parameter measurements can precede 
the Pao2 measurements and a graph similar to the one in Graph 7.1 can be 
generated for this specific patient; this will naturally render more 
accurate results. 
7.6 DERIVATION OF A NEW CLINICAL INDICATOR 
The more precise procedure as described in the previous section will render 
reliable results if the software and computer facilities are available. 
If the standard curves in Graph 7 .1 are used, it is difficult to relate 
the measured Pao2 values with a specific percentage of low blood distri-
bution and either one, or a combination of the two low V A/Q values. As 
explained previously the measured Pao2 values will in most cases repre-
sent a combination of these two series of distributions. 
A VA/Q index (IVA/Q) was defined instead, which requires the minimum of 
measurements and involves an easy algebraic calculation. 
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7.6.1 Definition of the VA/Q Index: The index is based on three consecutive 
measurements of Pao2 at a FI02 of 0,5; 0,8 and 1,0 respectively. These 
measurements should be preceded by measurements of the other model para-
meters if possible, otherwise standard values may be used instead. 
The definition of the index is illustrated in Graph 7.4. Line A-B 
represents the ideal case of two uniform compartments for the ventilation 
and perfusion respectively; this is the maximum possible Pa02 for the 
standard set of parameters. Two additional lines are illustrated C-D-E 
and F-G-H, which respectively represent line 9 (low VA/Q = 0,124) and 
line 4 (low VA/Q = 0,003) for the three FI02 values as discussed. 
The index is defined as that fraction of the area under the ideal line A-
B that is represented by the line formed by the three Pa02 points as 
measured. 
Area under the three measured points 
Area under ideal line A-B (7.1) 
A decrease in the index (maximum = 1) is therefore analogous to a more 
severe mismatch in the V A/Q distribution. It was previously stated that 
lines C-D-E and F-G-H are representative of the same degree of clinical 
severity. According to equation (7.1) this is however not the case; a 
compensating factor was therefore incorporated in the index. The 
compensation is based on the fact that the gradient of all lines 
interconnecting the points at FI02 = 0,8 and 0,1 in the low VA/Q = 0,124 
series exceed that of the ideal gradient A-B; the opposite is true for 
those gradients in the low V A/Q = 0,003 series. A compensating factor 
for the low VA/Q = 0,124 series was introduced, based on the gradient as 
discussed and which equates the index value for line C-D-E with that of 
line F-G-H. Depending on the position of the measured points, the 
compensating factor is decreased proportionally to the gradient until it 
equals the A-B gradient, in which case it is zero. Gradients less than 
that of A-B represent the low VA/Q = 0,003 series and in these cases the 
L .. factor reduces to zero. The compensation concept is illustrated in Fig. 
7.3. 
. . 










Gradient of the PaO, J 0,8-0,1 line 




low V AIQ = 0,003 
series 
Figure 7.3 VA/Q - Index canpensating factor. 
therefore redefined as follows: 
IiJA/Q 
A4 
= Al f(x) + 
f(x) {G4 -
Gl} . {A3 - A2} for f < 0 = (G2 - Gl) • Al 
f(x) = 0 for f > 0 
with reference to Graph 7.4: 
A1 the area under the ideal line A-B. 
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(7.2) 
A2 the area under the line connecting the three Pao2 points on line 9 
(VA/Q = 0,124). 
A3 the area under the line connecting the three Pa.02 points on line 4 
(V A/Q = 0,003) 
A4 the area under the line connecting the three Pa.02 p:)ints as mea-
sured at F1o2 = 0,5; 0,8 and 1,0. 
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Analogously G1, G2 and G4 are the respective gradients between the two 
Pao2 points at FI02 = 0,8 and 1,0. 
Ideally the model parameters should be measured and the points A, B, C, 
D, E, F, G and Has on Graph 7.4 should be generated for a specific 
patient; the parameters A1, A2, A3, G1, G4 are then determined for a 
specific case~ In the typical clinical situation the total pulmonary 
perfusion (Q), the oxygen consumption (V02) and the carbon dioxide output . 
(Vm2) are not always known (a Swan-Ganz catheter may for instance not be 
installed); in those cases the standard set of parameters should be 
assumed, in which case equation 7.2 simplifies to: 
= 0,15.Pa(50) + 0,25.Pa(80) + 0,1.Pa(lOO) _ O,(X)182 .f(x) 246,263 
f(x) = Pa(l(X)) - Pa(80) - 144,0 for f < o 
f(x) = o for f > o 
(7.3) 
Pa(50, Pa(80), Pa(lOO) are the arterial oxygen partial pressure measure-
ments at FI02 = 0,5; 0,8 and 1,0 respectively. 
The price paid for the lack of information is a reduced diagnostic sensi-
tivity; the results nevertheless contain more information than any of the 
other diagnostic indicators in the same category, (e.g. the physiological 
shunt). 
7.6.2 Clinical significance of the Vp/Q Index: The VA/Q index (as defined in 
equation 7.2) serves as an indicator of the shape of the VA/Q 
distribution and decreases with an increase in a VA/Q mismatch. The 
relationship is non-linear and is eluciated with reference to the 
respective distributions in graph 7.1; the clinical significance of the 
index value is obtained through correlation of the distributions in graph 
7.1 with the respective index values. The results of this exercise are 
displayed in Table 7.1 (the index values were calculated for the 
respective distributions represented in graph 7.1 and the standard 
parameters assumed as in equation 7.3). 
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It should be noted that the index values for the two extreme series of 
low VA/Q values differ for equal perfusion of these regions; this 
illustrates the fact that these conditions are representative of 
different degrees of clinical severity in the patient (as explained in 
paragraph 7.3). Furthermore a specific patient will in all probability 
display a combination of these two extremes, in which case the combined 
effect of the distributions in the patient will be reflected in the index 
value. 
With the preceding discussion in mind, it is possible to attach clinical 
judgements to the complete spectrum of the index value (0 to l); this has 
been done based on the discussion in paragraph 7 .3 and the correlations 
obtained through Table 7.1. Four major clinical judgements related to 
the nature of the V A/Q distribution in the patient, based on the index 
value, have been defined: i.e. a normal VA/Q distribution, a relatively 
safe region, a region where the patient is prone to develop severe VA/Q 










Figure 7.4 illustrates the clinical judgements that can be made about the 




normal V A/Q distribution 
relatively safe region 
patient prone to develop 
severe V A/Q abnormalities 
established ARDS 
(severe V AIQ mismatch) 
Figure 7.4 Clinical significance of the VA/Q - Index 
A very important aspect is the changes that may occur over a period of 
time in the index value. It is obvious that a downward trend of the 
index value is an indication of a deteriorating clinical picture. The 
index can also be used to detect early changes in the VA/Q distribution 
and can therefore be used in a predictive capacity. The complete 
clinical course should however be taken into consideration when the index 
is judged. An improvement of the index following fluid administration 
may only be. due to increased perfusion, without any real improvement of 
the adverse VA/Q distribution. The sensitivity of the index is indica-
tive of the extent to which misjudgements of this nature will be ex-
cluded, the details of which are addressed in the following section. 
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7.6.3 Sensitivity and Specificity of the· VA/Q Index: The following is under-
stood under the concepts of sensitivity and specificity pertaining to the 
VA/Q index: 
The diagnostic sensitivity and specificity of the index pertaining to the 
ARDS syndrome can only be defined once the exact correlation between the 
syndrome and the VA/Q distribution has been established (hypothesis I in 
this thesis). 
Specificity: the probability that if the index is calculated for a 
specific VA/Q distribution and set of theoretical parameters in the 
model, it will be equal to a similar VA/Q distribution and set of 
physiological parameters in the patient. 
The validity of the model was not addressed in this thesis, i.e. the 
physiological correctness of the equations used in the model have not 
been proved, it can nevertheless be assumed they are a reliable 
reflection of the actual state (refer to the citations in Chapter 5). 
Furthermore, the effect of nitrogen gas in the air and blood phase has 
been taken into consideration, which further contributes to its accuracy. 
It follows from this discussion that the index complies with a high 
specificity level. 
Sensitivity: the probability that if a specific VA/Q distribution does 
exist in the lung; the index as determined with the measurements will be 
a reflection of a similar theoretical VA/Q distribution in the model. 
It should be clear that the sensitivity of the index depends on the 
amount of information available pertaining to the true values of para-
meters within the patient. If all the parameters as required by the 
model are measured in the patient and the simulation completed for this 
specific case (equation 7.2 is applied to evaluate the index), it can be 
assumed that the index will exhibit a high sensitivity level as well. 
The oxygen consumption, carbon dioxide output, cardiac output and minute 
ventilation are not always readily available in the typical clinical 
situation. In the deriviation of equation 7.3 for the index it was 
therefore assumed that the standard set of parameters is valid for all 
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patients; this is not always true and will effect the index sensitivity. 
The effect on the model output due to deviations that might occur in the 
model parameters, was addressed in the model sensitivity analysis. The . . 
resulting changes in the VA/Q index were calculated for the maximum 
physiological deviations that may occur in the standard values and the 
results are presented in Appendix D. 
It is clear from these results that the only two parameters that could 
cause a severe misinterpretation of the index as illustrated in Fig. 7.4 
and calculated according to equation 7.3 are the total pulmonary capil-
lary perfusion (Q) and the oxygen consumption ('~02). An increase in vo2 
will however not lead to misinterpretation and as explained in a prece-
ding section, a decrease in vo2 is a consequence of other factors (prima-
rily a drop in Q); the actual oxygen demand in a patient is unlikely to 
decrease and will in most cases, in fact, increase • 
. 
That leaves Q as the only parameter which may lead to misinterpretation 
of the index due to deviations around the standard assumed value. The 
most marked effect .results from an increase in the standard value, which 
will cause an erroneously high index value, .when the VA/Q distribution is 
in fact severely affected. In this respect the clinical course and 
therapy must play an important role in the interpretation of the index. 
It should be emphasised that if all the parameters are measured (or at . 
least Q) and equation 7.2 is applied, the sensitivity problem can be 
minimised. 
To conclude; it should be clear that the VA/Q index, as introduced in the 
previous sections, exhibits a high sensitivity level if all the para-
meters as defined in paragraph 6.2.2 are known, if in the absence of 
enough clinical data these values are assumed to be equal to the standard 
values, the sensitivity of the index and therefore its ability to detect 
V A/Q inequalities, is still superior to other methods in use (e.g. the 
physiological shunt). 
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7.6.4 Method of physiological measurements: If the model parameters are to 
be measured in the patient (and the standard values are not assumed) this 
should be done at the onset of the series of Pao2 measurements and should 
be measured at the present Fio2 level set for the patient; since this is 
a true reflection of the combined clinical and therapeutic status. 
The series of three Pao2 measurements must be performed consecutively 
with approximately two minutes allowed for stabilisation of the Pao2 
level (Nunn, 1969) after the Fio2 has been set to 0,5; 0,8 and 1,0 
respectively. 
The patient should not be kept on these high levels of inspired oxygen 
for longer than the two minutes each, since it can affect the nature of 
the V A/Q distribution as well as other physiological variables. It is 
assumed that over a short period these parameters remain relatively 
constant and small changes will not affect the calculated index value. 
Since the respiratory system exhibits hysteresis (the Pao2 equilibrium 
time in the reverse direction is in excess of fifteen minutes comp:i.red to 
the two minutes in the forward direction) it is not advisable to compare 
the Pao2 measurements in a sequence of decreasing FI02; the results may 
be different since the actual shape of t he distribution may be affected 
by the longer periods of high FI02 levels. 
It was, for the purpose of this discussion, assumed that the patient is 
not presently on a FI02 level exceeding 0,5 (since the index is meant to 
be used primarily in a predictive capacity); the test can however be 
adapted to accommodate higher levels of Fio2• 
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8.1 CONCLUSIONS 
(a) The art of modelling complex biological systems and clinical 
application of results requires insight into as well as a thorough 
understanding of concepts related both to the biological and 
engineering sciences. 
(b) A mathematical model of a complex biological system can contribute 
towards the understanding of the interrelatedness of the various 
physiological parameters and processes, as well as clarification of 
causality principles. 
(c) Modelling and parameter identification techniques can be applied 
with success in the clinical environment in order to facilitate the 
management of patients. 
(d) The advent of ultra fast computers will greatly facilitate and 
enhance the simulation of biological systems. 
(e) The development of a computer program that guarantees the successful 
operation of a program over the complete range of all the 
physiological variables is a time consuming process and may present 
various problems related to numerical mathematics. 
(f) It is virtually imµ>ssible to grasp the inherent complexities of the 
respiratory system without the application of computer simulation 
techniques. 
(g) The VA/Q index as defined by the author can be applied in the 
clinical environment for the early identification of patients sus-
ceptible to ARDS as well as the management of any patient suffering 
from a mismatch in the VA/Q distribution. 
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8.2 RECOMMENDATIONS 
The following aspects justify further study: 
(a) Measurement of the VA/Q index in the clinical environment should be 
correlated with actual patient prognosis and other diagnostic 
indicators; with specific reference to patients susceptible to the 
ARDS syndrome. 
(b) The correlation between the onset of the ARDS syndrome and the 
nature of the VA/Q distribution should be studied in more detail. 
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APPta>IX A 
IOlEL PARAIIF::l'mS AND V.ARTABIJi8 
Al. INPUT VARIABLE 
fraction of inspired oxygen concentration fraction 






























amount by which the P50 (at 37°C; pH= 7,4; nmHg 
Pm2 = 40 mmHg) of the subject's blood 
exceeds the standard of 26,8 nmHg. 
blood temperature 
venous haemoglobin concentration 
arterial haemoglobin concentration 
solubility of nitrogen in blood 
BTPS to STFD conversion factor 
fraction of inspired carbon dioxide con-
centration 
fraction of inspired nitrogen concentra-
tion 
solubility of oxygen in blood 
venous haematocrit 
arterial haematocrit 
effective inspired gas pressure 
oxygen consumption 
carbon dioxide output 
nitrogen exchange in the lungs 
total inspired alveolar ventilation 
total pulmonary capillary perfusion 
number of canpartments in the lung 
g/100 ml blood 
g/100 ml blood 
ml N2/100 ml blood 
fraction 
fraction 

































number of modes in the ventilation distribution (maximum 2) 
mean value of mode 1 
standard deviation of mode 1 
skewing factor for mode 1 (left) 
skewing factor for mode 1 (right) 
'mean value of mode 2 
standard deviation of mode 2 
skewing factor for mode 2 (left) 
skewing factor for mode 2 (right) 
the mean ratio of the relative distribution of air between the 
modes. 
Perfusion distribution 
number of modes in the perfusion distribution (maximum 2) 
mean value of mode 1 
standard deviation of mode 1 
skewing factor for mode 1 (left) 
skewing factor for mode 1 (right) 
mean value of mode 2 
standard deviation of mode 2 
skewing factor for mode 2 (left) 
skewing factor for mode 2 (right) 
the percentage of the total perfusion to mode 1 







arterial oxygen partial pressure 
arterial carbon dioxide partial pressure 
arterial nitrogen partial pressure 
arterial oxygen content 
arterial carbon dioxide content 




ml 02/100 ml blood 
ml m2;100 ml blood 






















mixed venous oxygen partial pressure mmHg 
mixed venous carbon dioxide partial mmHg 
pressure 
mixed venous nitrogen partial pressure mmHg 
oxygen concentration in mixed venous blood ml 02/100 ml blood 
carbon dioxide concentration in mixed ml m2/100 ml blood 
venous blood 
nitrogen concentration in mixed venous 
blood 
alveolar oxygen partial pressure 
alveolar carbon dioxide partial pressure 
alveolar nitrogen partial pressure 
arterial pH 
venous pH 
resulting total alveolar ventilation 










Newton Raphson Algorithln 
Newton Raphson algorithm for solving the roots of a set of non-linear 
simultaneous equations. 
Assume the roots of the following set of n-simultaneous non-linear 
equations need to be solved: 
y = F (x) 
y n x 1 vector 
x n x 1 vector 
In order to solve the roots for the above set of equations, the following 
algorithm is iterated until such time that y approximates the zero vector 
close enough. 
1. y = F (x) 
2. X = X J-l * y 
3. Repeat 1 and 2 
J-1 the inverse n x n Jacobiaan matrix for the set of equations in 1 
(In those cases where it is not possible to derive exact equations for 
the respective partial derivatives, numerical differentiation techniques 
are applied. ) 
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APPfflDIX C 
.IKD.El. SffiSITIVITY ANALYSIS 
Cl. INTRODUCTION 
A parameter sensitivity index (SI) is defined as follows: 
SI = A parameter / other parameters constant 
The parameters are varied around the mean values as specified in 6.2.2 
with a plus and minus 10% deflection. 
C2. B100D TEMPERATURE SENSITIVITY 
Temp = 7,4°C 
Percentage of perfusion Sensitivity Index (SI) 
to the low VA/Q region FI02 
CL/blood) low VA/Q = 0,124 low VA/Q = 0,003 
0 0,50 -0,007 -0,007 
0.80 -0,003 -0,003 
0,99 -0,004 -0,004 
27,5 0,50 1,951 3,491 
0,80 0,010 4,235 
0,99 -0,017 3,932 
55 0,50 3,359 2,342 
0,80 0,422 2,566 
0,99 -0,163 2,702 
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C3. HB SENSITIVITY 
AHB = 3,1 g/100 ml blood 
Percentage of perfusion Sensitivity Index (SI) . . 
to the low VA/Q region FI02 
(L/blood) low VA/Q = 0,124 low VA/Q = 0,003 
0 0,50 -0,003 -0,003 
0,80 0,000 0,000 
0,99 0,000 0,000 
27,5 0,50 1,255 1,567 
0,80 0,012 2,306 
0,99 0,000 2,298 
55 0,50 1,565 1,174 
0,80 0,291 1,188 
0,99 0,001 1,202 
C4. HCRIT SENSITIVITY 
A HCRIT = 9,4 % 
Percentage of perfusion Sensi ti vi ty Index (SI) . . 
to the low VA/Q region FI02 
(L/blood) low VA/Q = 0,124 low VA/Q = 0,003 
0 0,50 -0,106 -0,106 
0,80 -0,185 -0,185 
0,99 -0,234 -0,234 
27,5 0,50 -0,085 o, 117 
0,80 -0,445 0,149 
0,99 -0,819 0,032 
55 0,50 0,138 0,043 
0,80 -0,860 0,068 
0,99 -1,915 0,096 
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C5. fEF SENSITIVITY 
Percentage of perfusion Sensitivity Index (SI) 
to the low VA/Q region FI02 
(L/blood) low VA/Q = 0,124 low VA/Q = 0,003 
0 0,50 0,430 0,430 
0,80 0,739 0,739 
0,99 0,933 0,933 
27,5 0,50 0,282 0,046 
0,80 0,702 0,190 
0,99 0,916 0,512 
55 0,50 0,064 0,015 
0,80 0,619 0,020 
0,99 0,889 0,024 
C6. vo2 SENSITIVITY 
. 
AV02 = 0,055 1/min 
Percentage of perfusion Sensitivity Index (SI) 
to the low VA/Q region FI02 
(L/blood) low VA/Q = 0,124 low VA/Q = 0,003 
0 0,50 -115,9 -115,9 
0,80 - 52,1 - 52,1 
0,99 - 12,2 - 12,2 
27,5 0,50 -828,1 -159,1 
0,80 -859,2 -522,6 
0,99 -226,5 -1176, 6 
55 0,50 -392,8 - 80,0 
0,80 -1974,1 - 92,6 
0,99 -852,6 -104,6 
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. 
C7. VOJ2 SENSITIVITY 
1/min 
Percentage of perfusion Sensitivity Index (SI) 
to the low VA/Q region FI02 
(L/blood) low VA/Q = 0,124 low VA/Q = 0,003 
0 0,50 - 75,7 - 75,7 
0,80 -130,0 -130,0 
0,99 -164,2 -164,2 
27,5 0,50 - 40,2 35,0 
0,80 -164,3 10,6 
0,99 -217,3 - 73,1 
55 0,50 22,9 25,5 
0,80 -209,4 26,4 
0,99 -319,5 26,4 
CB. ~ SENSITIVITY 
A VA = 1 1/min 
Percentage of perfusion Sensitivity Index (SI) 
to the low VA/Q region FI02 
(L/blood) low VA/Q = 0,124 low VA/Q = 0,003 
0 0,50 9,950 9,950 
0,80 8,953 8,953 
0,99 8,336 8,336 
27,5 0,50 5,888 -1,004 
0,80 10,123 0,481 
0,99 10,363 4,341 
55 0,50 -0,244 -1,028 
0,80 10,849 -1,222 
0,99 13,419 -1,285 
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C9. Q SENSITIVITY 
A Q = 1.18 1/rnin 
Percentage of perfusion Sensitivity Index (SI) 
to the low VA/Q region FI02 
(L/blood) low VA/Q = 0,124 low VA/Q = 0,003 
0 0,50 0,061 0,061 
0,80 0,074 0,074 
0,99 0,086 0,086 
27,5 0,50 35,371 6,809 
0,80 38,997 23,053 
0,99 11,691 53,403 
55 0,50 17,159 3,597 
0,80 92,760 4,295 
0,99 44,259 4,898 
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APPENDIX D 
SENSITIVITY ANALYSIS OF THE V A/Q INDEX ( Iv /Q) 
A 







% of total Standard 
low VA/Q perfusion to 
value low VA/Q region 1vA/Q 
unirrxxlal O 0,992 
0,124 27,5 0,682 
55,0 0,332 








% of total Standard 
low VA/Q perfusion to 
value low VA/Q region IvA/Q 
unirrxxlal 0 0,992 
0,124 27,5 0,682 
55,0 0,332 




































0 ,237 28,8 





0,685 0, 4 
0,338 1,8 
0,224 21,7 
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% change % change 
IvA/Q 
0,1 0,992 0 
0,1 0,683 0,1 
0 0,332 0 
15,2 0,212 15,2 
22,1 0,094 22,1 
Maximum 
% change % change 
IVA/Q 
-19,4 0,926 - 6,7 
-17,0 0,700 2,6 
-19,9 0,343 3,3 
-10,3 0,221 20,1 
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% of total 
low VA/Q perfusion to 

















































































D7. Parameters VA [1/min] 
Standard value 5,0 
minimum value 4,5 
maximum value 10,0 
% of total Standard Minimum Maximum 
low VA/Q perfusion to % change % change 
value low VA/Q region Iy j' AQ IvA/Q IvA/Q 
unimodal 0 0,992 0,982 - 1,0 1,041 4,9 
0,124 27,5 0,682 0,673 - 1,3 0,667 - 2,2 
55,0 0,332 0,326 - 1,8 0,361 8,7 
0,003 27,5 0,184 0,211 14,7 0,214 16,3 
55,0 0,077 0,095 23,4 0,086 11,7 
. 
D8. Parameter Q [1/min] 
Standard value 5,9 
minimum value 4,5 
maximum value 10,0 
% of total Standard Minimum Maximum 
low VA/Q perfusion to % change % change 
value low VA/Q region IvA/Q IVA/Q IVA/Q 
unimodal 0 0,992 0,992 0 0,993 0,1 
0,124 27,5 0,682 0,535 -21,6 0,890 30,5 
55,0 0,332 0,148 -55,4 0,768 131,3 
0,003 27,5 0,184 0,148 -19,6 0,427 132,1 
55,0 0,077 0,081 5,2 0,126 63,6 
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